e424b3
The information in
this prospectus supplement and the accompanying prospectus is
not complete and may be changed. This prospectus supplement and
accompanying prospectus are not an offer to sell these
securities and are not soliciting an offer to buy these
securities in any jurisdiction where the offer or sale is not
permitted.
|
Filed
Pursuant to Rule 424(b)(3)
Registration No. 333-162178
|
|
PROSPECTUS
SUPPLEMENT (Subject to Completion) |
Dated September 28, 2009 |
(To prospectus dated September 28, 2009)
2,500,000 Shares
Class A Common
Stock
We are selling 2,500,000 shares of Class A common
stock. Our Class A common shares are listed on the New York
Stock Exchange under the symbol MOG.A. On
September 24, 2009, the last reported sale price of our
Class A common stock was $31.41 per share.
Our business and an investment in our Class A common
stock involves significant risks. These risks are described
under the caption Risk Factors beginning on
page S-10 of this prospectus supplement, page 10 of
the accompanying prospectus and page 49 of our Annual
Report on Form 10-K for the year ended September 27,
2008.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus supplement or the accompanying prospectus. Any
representation to the contrary is a criminal offense.
|
|
|
|
|
|
|
|
|
|
|
Per Share
|
|
|
Total
|
|
|
Public offering price
|
|
$
|
|
|
|
$
|
|
|
Underwriting discounts and commissions
|
|
$
|
|
|
|
$
|
|
|
Proceeds, before expenses, to Moog
|
|
$
|
|
|
|
$
|
|
|
The underwriters may also purchase up to 375,000 shares of
our Class A common stock from us at the public offering
price, less underwriting discounts and commissions, to cover
overallotments.
The underwriters expect to deliver the shares in New York, New
York
on ,
2009.
Cowen and Company
,
2009
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
Prospectus Supplement
|
|
|
|
S-1
|
|
|
|
|
S-10
|
|
|
|
|
S-13
|
|
|
|
|
S-15
|
|
|
|
|
S-16
|
|
|
|
|
S-17
|
|
|
|
|
S-18
|
|
|
|
|
S-21
|
|
|
|
|
S-25
|
|
|
|
|
S-25
|
|
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
5
|
|
|
|
|
10
|
|
|
|
|
12
|
|
|
|
|
13
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
16
|
|
This prospectus supplement is a supplement to the
accompanying prospectus, dated September 28, 2009,
that is also a part of this document. This prospectus supplement
and the accompanying prospectus are part of a shelf registration
statement that we filed with the SEC. Under the shelf
registration process, we may offer from time to time an
indeterminate number of shares of our Class A common stock
under a new registration statement filed on September 28,
2009 (File
No. 333-162178).
In the accompanying prospectus, we provide you with a general
description of the securities we may offer from time to time
under our shelf registration statement. In this prospectus
supplement, we provide you with specific information about the
shares of our Class A common stock that we are selling in
this offering. This prospectus supplement and the prospectus and
the documents incorporated by reference herein and therein
include important information about us, our Class A common
stock being offered and other information you should know before
investing. This prospectus supplement also adds, updates, and
changes information contained in the prospectus. You should read
both this prospectus supplement and the accompanying prospectus
as well as additional information described under Where
You Can Find More Information on
page S-25
before investing in shares of our Class A common stock. If
the description of this offering or our operations varies
between the prospectus supplement and the accompanying
prospectus, you should rely on the information in this
prospectus supplement. The information contained in this
prospectus supplement and in the accompanying prospectus and the
documents incorporated by reference is accurate only as of their
respective dates, unless the information specifically indicates
another date applies regardless of the time of delivery of this
prospectus supplement and accompanying prospectus or of any sale
of our Class A common stock.
You should rely only on the information contained or
incorporated by reference in this prospectus supplement and the
accompanying prospectus or included in any free writing
prospectus that we may file with the SEC in connection with this
offering. We have not, and the underwriters have not, authorized
anyone to provide you with information that is different. We and
the underwriters are offering to sell and seeking offers to buy
shares of our Class A common stock only in jurisdictions
where offers and sales are permitted.
References to Moog refer to Moog Inc. Unless
otherwise indicated or the context otherwise requires,
references to we, us or our
refer collectively to Moog Inc. and its subsidiaries.
i
PROSPECTUS
SUPPLEMENT SUMMARY
The following summary supplements, is qualified in its
entirety by, and should be read in conjunction with, the more
detailed information and financial statements and notes thereto
appearing elsewhere, or incorporated by reference, in this
prospectus supplement and the accompanying prospectus. Before
you decide to invest in our Class A common stock, you
should carefully read the entire prospectus supplement, the
accompanying prospectus and the documents incorporated by
reference, including the sections entitled Risk
Factors in this prospectus supplement, the accompanying
prospectus and our Annual Report on
Form 10-K
for the year ended September 27, 2008 and the consolidated
financial statements and related notes, which are incorporated
by reference. Our fiscal year ends on the Saturday in September
or October that is closest to September 30. Unless
otherwise indicated, all information in this prospectus
supplement assumes the underwriters have not exercised their
overallotment option.
Our
Company
Overview
We are a worldwide designer, manufacturer and integrator of high
performance, precision motion and fluid controls and control
systems for a broad range of applications in aerospace and
defense, industrial and medical markets. Our aerospace and
defense products and systems include military and commercial
aircraft flight controls, satellite positioning controls,
controls for steering tactical and strategic missiles, thrust
vector controls for space launch vehicles, controls for gun
aiming, stabilization, and automatic ammunition loading for
armored combat vehicles, and homeland security products. Our
industrial products are used in a wide range of applications,
including injection molding machines, pilot training simulators,
wind energy, power generation, material and automotive testing,
metal forming, heavy industry and oil exploration. Our medical
products include infusion therapy pumps, enteral clinical
nutrition pumps, slip rings used on CT scanners, and motors used
in sleep apnea devices. For fiscal year 2008, our sales were
$1.903 billion, our net cash provided by operating activities
was $108 million and our net earnings were $119 million.
Our principal customers are Original Equipment Manufacturers, or
OEMs, and end users for whom we provide aftermarket support.
Aerospace and defense OEM customers collectively represented 44%
of our fiscal year 2008 sales. The majority of these sales were
to a small number of large companies. Due to the long-term
nature of many of the programs, many of our relationships with
aerospace and defense OEM customers are based on long-term
agreements. Our OEM sales of industrial and medical controls and
devices, which represented 38% of our fiscal year 2008 sales,
were to a wide range of global customers and were generally
based on lead times of 90 days or less. We also provide
aftermarket support, consisting of spare and replacement parts
and repair and overhaul services, for all of our product
applications. Our major aftermarket customers are the
U.S. Government and the commercial airlines. In fiscal year
2008, aftermarket sales accounted for 18% of total sales.
We have five operating segments: (1) Aircraft Controls,
(2) Space and Defense Controls, (3) Industrial
Systems, (4) Components, and (5) Medical Devices.
Our
Aircraft Controls Segment ($673 million, or 35%, of 2008
Sales)
Within Aircraft Controls, we design, manufacture and integrate
primary and secondary flight controls for military and
commercial aircraft, and provide aftermarket support. Our
systems are used in large commercial transports, supersonic
fighters, multi-role military aircraft, business jets and
rotorcraft. We also supply ground-based navigational aids.
We are well positioned on both development and production
programs. Typically, development programs require concentrated
periods of research and development by our engineering teams and
involve design, development, testing and integration. We are
currently working on several large development programs,
S-1
including the Lockheed Martin F-35 Joint Strike Fighter, Boeing
787 Dreamliner and Boeings extended range
747-8,
Airbus A350XWB and several business jet programs. The F-35 is in
the flight test phase and recently entered low rate initial
production. The 787 program began design and development in 2004
and is beginning to transition to production. The first flight
of the Boeing 787 Dreamliner is currently scheduled for the end
of calendar year 2009 with Boeings initial aircraft
delivery to occur by the end of calendar year 2010. The Airbus
A350XWB is in early stage development with entry into service
planned for 2013. Production programs are generally long-term
manufacturing efforts that extend for as long as the aircraft
builder receives new orders. Our large military production
programs include the
F/A-18 E/F
Super Hornet, the V-22 Osprey tiltrotor, the Black Hawk/Seahawk
helicopter and the F-15 Eagle. Our large commercial production
programs include the full line of Boeing 7-series aircraft,
Airbus A330/340 and a variety of business jets. Aftermarket
sales, which represented 32% of our fiscal year 2008 sales for
this segment, consist of the maintenance, repair, overhaul and
parts supply for both military and commercial aircraft. Our
aircraft products work in very demanding environments,
necessitating repair or replacement of parts from time to time.
Further, both our military and commercial customers throughout
the world carry spares inventory in order to minimize down time.
Our Space
and Defense Controls Segment ($253 million, or 13%, of 2008
Sales)
Our Space and Defense Controls segment provides controls for
satellites and space vehicles, armored combat vehicles, launch
vehicles, tactical and strategic missiles, homeland security and
other defense applications. For commercial and military
satellites, we design, manufacture and integrate steering and
propulsion controls and controls for positioning antennae and
deploying solar panels. The Atlas, Delta and Ariane launch
vehicle programs and the Space Shuttle use our steering and
propulsion controls. We are also developing products for the
Ares I launch vehicle and Orion crew vehicle on the
Constellation program, NASAs replacement for the Space
Shuttle. We supplied couplings, valves and actuators for the
International Space Station. We design and build steering and
propulsion controls for tactical and strategic missile programs,
including VT-1, Hellfire, TOW, Trident and Minuteman. We supply
valves and steering controls on the U.S. National Missile
Defense development initiative. We design and manufacture
systems for gun aiming, stabilization, automatic ammunition
loading and driver vision enhancement on armored combat vehicles
for a variety of international and U.S. customers,
including Krauss-Maffei Wegmann GmbH & Co. KG, Land
Systems Hägglunds AB, and General Dynamics. We also provide
sensor and surveillance systems for the homeland security market.
Our
Industrial Systems Segment ($532 million, or 28%, of 2008
Sales)
Industrial Systems serves a global customer base across a
variety of markets. Historically, our major markets have
included plastics making machinery, simulation, power
generation, test, metal forming and heavy industry. Sales into
those markets accounted for over 60% of our total sales in this
segment. The recent global recession has significantly affected
our sales in most of our industrial markets in 2009. For the
plastics making machinery market, we design, manufacture and
integrate systems for all axes of injection and blow molding
machines using leading edge technology, both hydraulic and
electric. We supply electromechanical motion simulation bases
for the flight simulation and training markets. In the power
generation market, we design, manufacture and integrate complete
control assemblies for fuel, steam and variable geometry control
applications that include wind turbines. For the test markets,
we supply controls for automotive, structural and fatigue
testing. Metal forming markets use our systems to provide
precise control of position, velocity, force, pressure,
acceleration and other critical parameters. Heavy industry uses
our high precision electrical and hydraulic servovalves for
steel and aluminum mill equipment. Other markets include oil
exploration, material handling, auto racing, carpet tufting,
paper and lumber mills. In addition, recent acquisitions have
allowed us to target wind energy as a new market. For wind
energy, we make electric rotor blade controls and blade
monitoring systems for wind turbines. We expect this new wind
energy market to be our strongest industrial market in 2010 as
measured by sales.
Our
Components Segment ($341 million, or 18%, of 2008
Sales)
The Components segment serves many of the same markets as our
other segments. The Components segments three largest
product categories are slip rings, fiber optic rotary joints and
motors.
S-2
Slip rings and fiber optic rotary joints accounted for
approximately 60% of our fiscal year 2008 sales for this
segment and use sliding contacts and optical technology to allow
unimpeded rotation while delivering power and data through a
rotating interface. They come in a range of sizes that allow
them to be used in many applications, including diagnostic
imaging CT scan medical equipment featuring high-speed data
communications, de-icing and data transfer for rotorcraft,
forward-looking infrared camera installations, radar pedestals,
surveillance cameras and remotely operated vehicles for offshore
oil exploration. Our motors are used in an equally broad range
of markets, many of which are the same as for slip rings.
Components designs and manufactures a series of miniature
brushless motors that provide extremely low noise and reliable
long life operation, with the largest market being sleep apnea
equipment. Industrial markets use our motors for material
handling and electric pumps. Military applications use our
motors for gimbals, missiles and radar pedestals.
Components other product lines include electromechanical
actuators for military, aerospace and commercial applications,
fiber optic modems that provide
electrical-to-optical
conversion of communication and data signals, avionic
instrumentation, optical switches and resolvers.
Our
Medical Devices Segment ($103 million, or 6%, of 2008
Sales)
This segment operates within four medical devices market areas:
infusion therapy, enteral clinical nutrition, sensors and
surgical handpieces. For infusion therapy, our primary products
are electronic ambulatory infusion pumps along with the
necessary administration sets as well as disposable infusion
pumps. Applications of these products include hydration,
nutrition, patient controlled analgesia, local anesthesia,
chemotherapy and antibiotics. We manufacture and distribute a
complete line of portable pumps, stationary pumps and disposable
sets that are used in the delivery of enteral nutrition for
patients in their own homes, hospitals and long-term care
facilities. We manufacture and distribute ultrasonic and optical
sensors used to detect air bubbles in infusion pump lines and
ensure accurate fluid delivery. Our surgical handpieces are used
to safely fragment and aspirate tissue in common medical
procedures such as cataract removal.
Our
Markets
We operate within the aerospace and defense, industrial and
medical markets. Our aerospace and defense markets are affected
by market conditions and program funding levels, while our
industrial markets are influenced by general capital investment
trends. Our medical markets are influenced by economic
conditions, hospital and outpatient clinic spending on
equipment, population demographics, medical advances and patient
demand. A common factor throughout our markets is the continuing
demand for technologically advanced products.
Aerospace
and Defense
The military aircraft market is dependent on military spending
for development and production programs. Production programs are
typically long-term in nature, offering predictability as to
capacity needs and future revenues. We maintain positions on
numerous high priority programs, including the F-35 Joint Strike
Fighter, the
F/A-18 E/F
Super Hornet and V-22 Osprey. The large installed base of our
products leads to attractive aftermarket sales and service
opportunities. Aftermarket revenues are expected to continue to
grow due to a number of scheduled military retrofit programs and
increased flight hours resulting from increased military
commitments.
The commercial OEM market has historically exhibited cyclical
swings and sensitivity to economic conditions. The aftermarket
is driven by usage of the existing aircraft fleet, the age of
the installed fleet and is currently being impacted by fleet
re-sizing programs for passenger and cargo aircraft. Changes in
aircraft utilization rates affect the need for maintenance and
spare parts and impact aftermarket sales. Boeing and Airbus have
historically adjusted production in line with air traffic volume.
The military and government space market is primarily dependent
on the authorized levels of funding for satellite
communications. Government spending on military satellites has
risen in recent years as the militarys need for improved
intelligence gathering has increased. The commercial space
market is comprised of large satellite customers, traditionally
telecommunications companies. Trends for this market, as well as
for commercial launch vehicles, follow telecommunications
companies need for increased capacity and the satellite
replacement lifecycle
S-3
of 7-10 years. Our position on NASAs Constellation
program for crew transportation to the Space Station and the
exploration of the Moon, and possibly Mars, holds the potential
to be a long-run production program.
The tactical and strategic missile and defense controls markets
are dependent on many of the same market conditions as military
aircraft, including overall military spending and program
funding levels. Our homeland security product line is dependent
on government funding at federal and local levels, as well as
private sector demand.
Industrial
The industrial markets we serve are influenced by several
factors, including capital investment, product innovation,
economic growth, cost-reduction efforts and technology upgrades.
The industrial markets are experiencing challenges from current
global economic conditions. These challenges include reacting to
slowing demand for industrial automation equipment, steel and
automotive manufacturing and delayed orders as customers manage
inventory levels. Despite the general slowdown in demand from
the global recession, we continue to see strong demand in the
growing wind energy market.
Medical
The medical markets we serve are influenced by economic
conditions, hospital and outpatient clinic spending on
equipment, population demographics, medical advances, patient
demands and the need for precision control components and
systems. Advances in medical technology and medical treatments
have had the effect of extending the average life span, in turn
resulting in greater need for medical services. These same
technology and treatment advances also drive increased demand
from the general population as a means to improve quality of
life. Greater access to medical insurance, whether through
government funded health care plans or private insurance, also
increases the demand for medical services.
Our
Business Strengths
Since our founding in 1951, we have concentrated on providing
our customers with products designed and manufactured to the
highest quality standards. In achieving a leadership position in
the high performance, precision controls market, we have
capitalized on our strengths, which include:
Superior technical competence and customer intimacy breed
market leadership. Our innovative approach to
working closely with our customers to solve their controls needs
has been a very successful strategy for us. We attract and
retain some of the best and brightest engineers who have solved
some of the most difficult motion control problems. We designed
and supply the flight controls on the V-22 Osprey and F-35 Joint
Strike Fighter. By solving our customers complex design
and development challenges, we obtain substantial follow-on
production and aftermarket business. As a result, we believe we
are a leader in most of the markets we serve, including aircraft
flight controls, space and defense steering and fuel controls
and certain industrial controls.
Customer diversity and broad product
portfolio. We have focused on building our
business based on a balanced portfolio of OEM and aftermarket
customers. Aerospace and defense OEM customers collectively
represented 44% of our fiscal year 2008 sales, with the majority
of these sales to a small number of large companies. Our OEM
sales of industrial and medical controls and devices, which
represented 38% of our fiscal year 2008 sales, were to a wide
range of global customers. We also provide aftermarket support,
consisting of spare and replacement parts and repair and
overhaul services, for all of our product applications. Our
major aftermarket customers are the U.S. Government and the
commercial airlines. The breadth of our product range includes
electrohydraulic, electromechanical, electrohydrostatic and
electric controls as well as control software, allowing each of
our segments to reach numerous markets.
Well-established international presence serving customers
worldwide. We have a well-established
international presence throughout Europe, Asia and South
America. We entered mainland China in 1997, and our Chinese
operations have enjoyed rapid sales growth. Our reputation for
superior quality performance has helped to expand our marketing
reach in demanding global controls markets. Our network of
well-established subsidiaries
S-4
in the Americas, Europe and Asia allows us to effectively
address our customers needs, wherever they may be located.
In fiscal year 2008, 20% of our sales came from our European
operations, 7% from our Asian operations, and the balance were
generated from the Americas, predominantly the United States.
Our principal manufacturing operations are located in the United
States, the Philippines, Germany, England, Italy, Japan, China,
Ireland, India and Luxembourg.
Proven ability to successfully integrate
acquisitions. We have acquired numerous
companies over the last 15 years. Our success in
integrating these acquired businesses into our existing
operations and gaining the benefit of available synergies is
evidenced by our long-term sales growth and net earnings growth.
Our organic sales growth of 9% compounded annually for 1994 to
2008 complements our growth through acquisitions.
Our
Business Strategy
We intend to increase our revenue base and improve our
profitability and cash flows from operations by building on our
market leadership positions, by strengthening our niche market
positions in the principal markets we serve and by extending our
participation on the platforms we supply by providing more
systems solutions. We also expect to maintain a balanced,
diversified portfolio in terms of markets served, product
applications, customer base and geographic presence. Our
strategy to achieve our objectives includes:
Maintaining our technological excellence by building upon
our systems integration capabilities while solving our
customers most demanding technical
problems. Our historical commitment to
technological superiority is demonstrated by our past work on
significant programs such as the F-15 Eagle, B-2 stealth bomber,
Space Shuttle, Boeing 7 series, and V-22 Osprey. We believe our
successes in being selected to supply control systems on a
number of significant applications, including the F-35 Joint
Strike Fighter, Boeing 787, Airbus A350XWB, NASAs
Constellation program, electric motion simulators for flight
training, and flight control electronics on the high capacity
Boeing
747-8,
demonstrate our commitment to remain on the leading edge of
technological advancements. These recent program successes for
the newer design and development initiatives serve to further
broaden our technological capabilities and strengthen our market
leadership position. By taking advantage of our strong market
share, particularly in the high-end precision control markets,
we continue to build our credentials as an innovative, capable
and reliable systems integrator and subsystems supplier.
Taking advantage of our global
capabilities. Our global network of
international subsidiaries, in combination with our strong base
in the U.S., provides us with unique opportunities to reach
across the global markets we serve. For example, our aerospace
OEM activity is concentrated in the U.S. and Europe, while
our aerospace aftermarket business is global in nature. Our
industrial business is also global in nature. Our operating
philosophy is to identify centers of excellence for design,
manufacture and aftermarket service to enable our subsidiaries
to concentrate on what they do best. Certain of our subsidiaries
are staffed principally by sales and applications engineers who
then tap resources elsewhere in our network of companies. With
our objective of providing increasing value to our customers, we
are able to take advantage of the synergies that result from
sharing resources and capabilities across our operating units
throughout the world.
Growing our profitable aftermarket
business. We market spare and replacement
parts and repair services directly to our aerospace, industrial
and medical customers through our extensive network of
U.S. operations and international subsidiaries. Our
aftermarket business generally is more profitable than our OEM
business, and it provides a continuing revenue stream for many
years after the end of OEM production. We have a dedicated
customer service organization responsive to our aftermarket
customers needs.
Capitalizing on strategic acquisitions and
opportunities. We intend to enhance our
existing product offerings through continued investment in
independent research and development activities, teaming with
our customers in development initiatives, and selective,
strategic acquisitions. We have made several acquisitions that
have broadened our product offerings and markets we serve. A
recent example is the acquisition of LTi REEnergy GmbH. LTi
REEnergy specializes in the design and manufacture of servo
controllers as well as complete drive systems for electric rotor
blade controls for wind turbines, and provides us greater
opportunities in the wind energy market.
S-5
Entering and developing new markets. We
expect to expand our capabilities into new, growing markets by
focusing on markets that are compatible with our precision
controls competence. Recent examples are our entry into the
homeland security and medical devices markets. Our broad
expertise as a designer and supplier of precision controls
allows us to consider entering new markets, generally at the
high end of the performance spectrum.
Striving for continuing cost
improvements. We continue to pursue cost and
cycle time reductions using lean initiatives to improve
efficiency and maximize value to our stakeholders. Our
well-established low-cost manufacturing centers in the
Philippines and India provide us with a competitive advantage on
long-term production programs.
Recent
Developments
One of our business strategies is to grow through acquisitions
of complementary businesses. We are continually evaluating new
business opportunities in our existing markets and may enter
into an acquisition agreement at any time. On September 25,
2009, we acquired the flight control actuation business of GE
Aviation Systems, an operating unit of General Electric Company,
or GE, located in Wolverhampton, England. GE acquired this
business as a part of its acquisition of Smiths Aerospace in May
2007.
The Wolverhampton operation designs and manufactures primary and
secondary flight control actuation for a number of commercial
and military programs. It supplies high-lift actuation systems
for the Boeing 777 and 787 and the Airbus A330 and A380.
Wolverhampton also provides primary flight controls for the
European fighter, Typhoon, and a main engine lift system for the
Rolls-Royce engine on the STOVL version of the F-35 Joint Strike
Fighter.
The Wolverhampton business is complementary to Moogs
Aircraft Controls Segment. Wolverhampton sales for the calendar
year 2008 were approximately $100 million. Exclusive of our
acquisition of the Wolverhampton operation, Moogs Aircraft
Controls segment is projecting fiscal year 2009 sales of
$652 million. Moogs total sales for fiscal year 2009
are projected at just over $1.8 billion. Moogs
Aircraft Controls segment is projecting fiscal year 2010 sales,
including Wolverhampton, of approximately $746 million.
Consolidated fiscal year 2010 sales, including Wolverhampton,
are now projected to be $2.130 billion. Assuming the sale
of 2,500,000 shares of our Class A common stock in
this offering at our September 24, 2009 closing sale price
of $31.41, and applying the net proceeds to repay a portion of
the indebtedness incurred in the acquisition as described in the
Use of Proceeds section of this prospectus
supplement, would result in expected dilution of $0.10 per share
to Moogs forecasted fiscal year 2010 earnings per share.
Forecasted fiscal year 2010 cash flow from operations less
capital expenditures is expected to be unaffected by this
acquisition.
We were incorporated in New York in 1951. Our principal
executive offices are located at Seneca St. at Jamison Road,
East Aurora, New York 14052, and our telephone number is
(716) 652-2000.
Our internet address is www.moog.com. Our internet site is not
incorporated into this prospectus supplement.
S-6
The
Offering
|
|
|
Class A common stock offered hereby |
|
2,500,000 shares |
|
Option to purchase additional shares |
|
We have granted the underwriters a
30-day
option to purchase up to 375,000 additional shares of
Class A common stock. |
|
Common stock outstanding after the offering |
|
|
|
Class A common
stock(1) |
|
40,992,674 shares |
|
Class B common
stock(2) |
|
4,139,606 shares |
|
Total |
|
45,132,280 shares |
|
Use of Proceeds |
|
We expect to use the net proceeds from this offering to pay for
our acquisition of the flight control actuation product line of
GE Aviation Systems, an operating unit of General Electric
Corporation, or if we do not close that acquisition, to repay a
portion of the outstanding indebtedness under our revolving bank
credit facility, which amount may be borrowed for general
corporate purposes, including other acquisitions. See Use
of Proceeds. |
|
Conflicts of Interest |
|
As described in Use of Proceeds, some of the net
proceeds of this offering may be used to repay a portion of the
outstanding indebtedness under our revolving credit facility
portion of our bank credit facility. Because more than 5% of the
proceeds of this offering, not including underwriting
compensation, may be received by one of the underwriters in this
offering or by one of their affiliates, this offering is being
conducted in compliance with NASD Rule 2720, as
administered by the Financial Industry Regulatory Authority
(FINRA). Pursuant to that rule, the appointment of a
qualified independent underwriter is not necessary in connection
with this offering, as the offering is of a class of equity
securities for which a bona fide public market, as
defined by FINRA rules, exists. |
|
Risk Factors |
|
You should carefully consider the information set forth under
Risk Factors beginning on
page S-10
of this prospectus supplement, on page 10 of the
accompanying prospectus and on page 49 of our Annual Report
on
Form 10-K
for the year ended September 27, 2008 before investing in
our Class A common stock. |
|
NYSE symbols: |
|
|
|
Class A common stock |
|
MOG.A |
|
Class B common stock |
|
MOG.B |
|
|
|
(1) |
|
The number of shares of our Class A common stock that will
be outstanding after the offering is based on
38,492,674 shares of Class A common stock outstanding
as of September 24, 2009 and excludes: |
|
|
|
|
|
1,699,886 shares of Class A common stock issuable upon
exercise of outstanding stock options under our stock option
plans as of September 24, 2009 at a weighted average
exercise price of $26.27 per share;
|
|
|
|
13,192 shares of Class A common stock reserved and
available for future issuance under our stock option plans as of
September 24, 2009;
|
S-7
|
|
|
|
|
4,139,606 shares of Class A common stock issuable upon
conversion of our shares of Class B common stock
outstanding as of September 24, 2009;
|
|
|
|
shares available under employee benefit plans for future
grants; and
|
|
|
|
up to 375,000 shares of Class A common stock that may
be issued to the underwriters upon exercise of their
overallotment option.
|
|
|
|
(2) |
|
The number of outstanding shares of Class B common stock
shown is based on the number of shares of Class B common
stock outstanding as of September 24, 2009. Shares of our
Class B common stock are convertible into shares of
Class A common stock on a
one-for-one
basis. On all matters, other than the election of directors or
as required by law, the Class A common stock and Class B
common stock vote as a single class with each share of
Class A common stock entitled to a one-tenth vote per share
and each share of Class B common stock entitled to one vote
per share. |
See Description of Capital Stock in the accompanying
prospectus for additional information on our Class A common
stock and our Class B common stock.
S-8
Summary
Financial Data
The following table summarizes our financial statement data and
other operating information for each of the fiscal years in the
three-year period ended September 27, 2008 and for the
nine-month periods ended June 28, 2008 and June 27,
2009. The summary financial information for the three-year
period ended September 27, 2008 has been derived from our
audited financial statements with the exception of the
12-month
backlog. The summary financial information for the nine-month
periods ended June 28, 2008 and June 27, 2009, has
been derived from our unaudited financial statements. The
results of operations for the nine-month period ended
June 27, 2009 are not necessarily indicative of the results
to be expected for a full fiscal year. The financial statement
data should be read in conjunction with our financial statements
and the notes thereto contained in our Annual Report on
Form 10-K
for the fiscal year ended September 27, 2008 and our
Quarterly Report on
Form 10-Q
for the nine-month period ended June 27, 2009.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
|
|
|
Fiscal Year
|
|
|
June 28,
|
|
|
June 27,
|
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2008
|
|
|
2009
|
|
|
|
(Dollars in thousands)
|
|
|
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$
|
1,306,494
|
|
|
$
|
1,558,099
|
|
|
$
|
1,902,666
|
|
|
$
|
1,411,820
|
|
|
$
|
1,344,583
|
|
Cost of sales
|
|
|
880,744
|
|
|
|
1,028,852
|
|
|
|
1,293,452
|
|
|
|
956,064
|
|
|
|
945,213
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
|
425,750
|
|
|
|
529,247
|
|
|
|
609,214
|
|
|
|
455,756
|
|
|
|
399,370
|
|
Research and development
|
|
|
68,886
|
|
|
|
102,603
|
|
|
|
109,599
|
|
|
|
80,686
|
|
|
|
72,127
|
|
Selling, general and administrative
|
|
|
213,657
|
|
|
|
252,173
|
|
|
|
294,936
|
|
|
|
219,634
|
|
|
|
208,550
|
|
Restructuring
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,946
|
|
Interest
|
|
|
21,861
|
|
|
|
29,538
|
|
|
|
37,739
|
|
|
|
28,056
|
|
|
|
28,494
|
|
Other
|
|
|
1,197
|
|
|
|
1,182
|
|
|
|
(1,095
|
)
|
|
|
(1,746
|
)
|
|
|
(9,014
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings before income taxes
|
|
|
120,149
|
|
|
|
143,751
|
|
|
|
168,035
|
|
|
|
129,126
|
|
|
|
89,267
|
|
Income taxes
|
|
|
38,803
|
|
|
|
42,815
|
|
|
|
48,967
|
|
|
|
41,712
|
|
|
|
19,409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
81,346
|
|
|
$
|
100,936
|
|
|
$
|
119,068
|
|
|
$
|
87,414
|
|
|
$
|
69,858
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
57,821
|
|
|
$
|
83,856
|
|
|
$
|
86,814
|
|
|
$
|
85,092
|
|
|
$
|
77,014
|
|
Working capital
|
|
|
420,495
|
|
|
|
616,623
|
|
|
|
713,292
|
|
|
|
716,135
|
|
|
|
747,811
|
|
Total assets
|
|
|
1,607,654
|
|
|
|
2,006,179
|
|
|
|
2,227,247
|
|
|
|
2,238,786
|
|
|
|
2,503,273
|
|
Total debt
|
|
|
386,558
|
|
|
|
617,523
|
|
|
|
671,060
|
|
|
|
688,998
|
|
|
|
831,248
|
|
Shareholders equity
|
|
|
762,856
|
|
|
|
877,212
|
|
|
|
994,410
|
|
|
|
962,813
|
|
|
|
1,056,439
|
|
Other Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
$
|
76,875
|
|
|
$
|
25,084
|
|
|
$
|
107,892
|
|
|
$
|
55,562
|
|
|
$
|
83,901
|
|
Net cash used in investing activities
|
|
|
(169,671
|
)
|
|
|
(230,880
|
)
|
|
|
(148,880
|
)
|
|
|
(120,104
|
)
|
|
|
(217,737
|
)
|
Net cash provided by financing activities
|
|
|
114,965
|
|
|
|
226,671
|
|
|
|
42,472
|
|
|
|
60,118
|
|
|
|
126,364
|
|
Depreciation and amortization
|
|
|
47,077
|
|
|
|
52,093
|
|
|
|
63,376
|
|
|
|
46,723
|
|
|
|
55,448
|
|
Capital expenditures
|
|
|
83,555
|
|
|
|
96,988
|
|
|
|
91,833
|
|
|
|
68,526
|
|
|
|
64,111
|
|
12-month
backlog
|
|
|
645,032
|
|
|
|
774,548
|
|
|
|
861,694
|
|
|
|
873,344
|
|
|
|
992,202
|
|
S-9
RISK
FACTORS
Investing in our Class A common stock involves a high
degree of risk. Before you invest in our Class A common
stock, you should understand and carefully consider the risks
described below, the risks described under the heading
Risk Factors on page 10 of the accompanying
prospectus and the risk factors relating to our industry and our
business described in our Annual Report on
Form 10-K
for the year ended September 27, 2008, as well as all of
the other information contained in this prospectus supplement,
the accompanying prospectus and the information incorporated by
reference, including our financial statements and the related
notes. Any of these risks could materially adversely affect our
business, financial condition, results of operations and the
trading price of our Class A common stock, and you may lose
all or part of your investment.
The
voting rights of the Class A common stock are
limited.
The voting rights of the holders of Class A common stock
are limited by our certificate of incorporation. Holders of
Class A common stock are entitled to elect at least 25% of
the board of directors, rounded up to the nearest whole number,
so long as the outstanding shares of Class A common stock
are at least 10% of the aggregate number of outstanding shares
of Class A common stock and Class B common stock
combined. Currently, the holders of Class A common stock
are entitled, as a class, to elect three directors. The holders
of the Class B common stock are entitled, as a class, to
elect the remaining eight directors. On all other matters except
as is required by law, the Class A and Class B common
stock vote together as a single class with each share of
Class A common stock entitled to a one-tenth vote per share
and each share of Class B common stock entitled to one vote
per share.
Our
officers and directors and shareholders affiliated with them
control the vote of a significant percentage of our voting stock
and as a result exert influence over us, and may have interests
that conflict with those of other shareholders, including
purchasers of Class A common stock.
As of September 24, 2009, 85.1% of the Class B common
stock and 4.9% of the Class A common stock was held in the
aggregate by the Moog Inc. Retirement Savings Plan Trust, the
Moog Inc. Retirement Plan Trust, relatives of the late Jane B.
Moog subject to The Moog Family Agreement as to Voting and our
officers and directors. These shareholders as a group possess
the voting power to elect a majority of the board of directors
and to effectively control our business policies and affairs,
and may have interests that conflict with those of the other
shareholders, including purchasers of our Class A common
stock.
New York
law and our certificate of incorporation and by-laws contain
provisions that could delay and discourage takeover attempts
that shareholders may consider favorable.
Certain provisions of our certificate of incorporation and
by-laws and applicable provisions of New York corporate law may
make it more difficult for, or prevent, a third party from
acquiring control of us or changing our board of directors and
management. These provisions include:
|
|
|
|
|
the limited voting rights of the Class A common stock and
the fact that 4.9% of the Class A and 85.1% of the
Class B common stock, representing 48.1% of the voting
power of our outstanding common stock, is owned or controlled by
our affiliates;
|
|
|
|
our ability under our certificate of incorporation to issue
additional shares of Class B common stock and shares of
blank check preferred stock without action of the
shareholders;
|
|
|
|
provisions of our certificate of incorporation and by-laws which
create a staggered board of directors with each director elected
for a three-year term; and
|
|
|
|
provisions of New York corporate law which impose limitations on
persons proposing to acquire us in a transaction not approved by
our board of directors.
|
Any delay or prevention of a change of control transaction or
changes in our board of directors or management could deter
potential acquirors or prevent the completion of a transaction
in which our stockholders could receive a substantial premium
over the then-current market price for their shares.
S-10
Possible
volatility in the price of our common stock could negatively
affect us and our shareholders.
The trading price of our Class A common stock may be
volatile in response to a number of factors, many of which are
beyond our control, including actual or anticipated variations
in quarterly financial results, changes in financial estimates
by securities analysts and announcements by our competitors of
significant acquisitions, strategic partnerships, joint ventures
or capital commitments. In addition, our financial results may
be below the expectations of securities analysts and investors.
If this were to occur, the market price of our Class A
common stock could decrease, perhaps significantly.
Additionally, our Class A common stock has historically had
low trading volumes. The limited liquidity for holders of our
Class A common stock may add to the volatility of the
trading price of our common stock. For example, from
October 1, 2007 to September 24, 2009, the sales
prices of our Class A common stock have ranged from $17.90
per share to $56.47 per share. These effects could materially
adversely affect the trading market and prices for our
Class A common stock, as well as our ability to issue
additional securities or to secure additional financing in the
future.
In addition, the U.S. securities markets have experienced
significant price and volume fluctuations. These fluctuations
often have been unrelated to the operating performance of
companies in these markets. Broad market and industry factors
may negatively affect the price of our Class A common
stock, regardless of our operating performance.
Future
sales of shares of our common stock may depress its market
price.
Sales of substantial numbers of additional shares of common
stock, including shares of our Class A common stock, as
well as sales of shares that may be issued in connection with
future acquisitions or for other purposes, including to finance
our operations and business strategy, or the perception that
such sales could occur, may have a harmful effect on prevailing
market prices for our Class A common stock and our ability
to raise additional capital in the financial markets at a time
and price favorable to us.
You may
not receive dividends on our Class A common
stock.
Holders of our Class A common stock are only entitled to
receive such dividends as our board of directors may declare out
of funds legally available for such payments. Covenants
contained in our debt agreements limit the payment of dividends
on our Class A common stock. Furthermore, our certificate
of incorporation permits our board of directors to declare and
issue preferred stock with dividend rights that rank prior in
right of payment to the Class A common stock without
further approval by holders of Class A common stock. We did
not pay cash dividends on our Class A common stock or
Class B common stock in 2007 or 2008 and have no plans to
do so in the foreseeable future.
Any
issuance of preferred stock could adversely affect the holders
of our Class A common stock.
Our board of directors is authorized to issue shares of
preferred stock or Class B common stock without any action
on the part of our shareholders. Our board of directors also has
the power, without shareholder approval, to set specified terms
of any series of preferred stock, including dividend rates,
votes per share, redemption prices and amounts payable in the
event of our dissolution, liquidation or winding up. Any
preferred stock that we issue may have a preference over our
Class A common stock with respect to the payment of
dividends and upon our liquidation, dissolution or winding up.
As a result, our board of directors could issue preferred stock
with dividend, liquidation and voting rights and with other
terms that could adversely affect the interests of the holders
of our Class A common stock.
If we do
not successfully integrate the flight control actuation business
of GE Aviation Systems into our business operations, our
business could be adversely affected.
Upon the close of the acquisition, we will need to successfully
integrate the operations of the flight control actuation
business of GE Aviation Systems with our business operations.
Integrating the operations of the flight control actuation
business with that of our own will be a complex and
time-consuming process. Prior to the acquisition, the flight
control actuation business operated independently, with its own
business, corporate culture,
S-11
locations, employees and systems. There may be substantial
difficulties, costs and delays involved in any integration of
the business of the flight control actuation business with that
of our own. These may include:
|
|
|
|
|
diversion of management time and attention from our core
business;
|
|
|
|
the potential exposure to unanticipated liabilities;
|
|
|
|
the potential that expected benefits or synergies are not
realized and that operating costs increase;
|
|
|
|
difficulties in integrating the operations and personnel of the
acquired business; and
|
|
|
|
the potential loss of key employees, suppliers or customers of
acquired business.
|
Many of these risks are accentuated because the operations,
employees and customers of the flight control actuation business
are largely located outside of the United States. Any one or all
of these factors may increase operating costs or lower
anticipated financial performance. Many of these factors are
also outside of our control. Achieving anticipated synergies and
the potential benefits underlying our reasons for the
acquisition will depend on successful integration of the
businesses. The failure to integrate the business operations of
the flight control actuation product line successfully would
have a material adverse effect on our business, financial
condition and results of operations.
S-12
DISCLOSURE
REGARDING FORWARD-LOOKING STATEMENTS
This prospectus supplement, including the documents we
incorporate by reference, contains forward-looking statements
within the meaning of Section 27A of the Securities Act and
Section 21E of the Securities Exchange Act. These
statements are included throughout this prospectus supplement,
including in the sections entitled Prospectus Supplement
Summary and Risk Factors. These
forward-looking statements are not historical facts, but only
predictions and generally can be identified by the use of terms
such as may, will, should,
believes, expects, expected,
intends, plans, projects,
estimates, predicts,
potential, outlook,
forecast, anticipates,
presume, assume, and terms and phrases
of similar import. Although we believe the assumptions upon
which these forward-looking statements are based are reasonable,
any of these assumptions could prove to be inaccurate, and the
forward-looking statements based on these assumptions could be
incorrect. While we have made these forward-looking statements
in good faith and they reflect our current judgment regarding
such matters, actual results could vary materially from the
forward-looking statements. Accordingly, these forward-looking
statements are qualified in their entirety by reference to the
factors described in Risk Factors appearing in this
prospectus supplement and the accompanying prospectus as well as
to other information in this prospectus supplement, the
accompanying prospectus and the documents incorporated by
reference. The forward-looking statements included in this
prospectus supplement are made only as of their respective
dates, and we undertake no obligation to publicly update these
forward-looking statements to reflect new information, future
events or otherwise. In light of these risks, uncertainties and
assumptions, the forward-looking events might or might not
occur. Actual results and trends in the future may differ
materially depending on a variety of important factors. The
factors identified below are not exhaustive. New factors, risks
and uncertainties may emerge from time to time that may affect
the forward-looking statements made herein. Given these factors,
risks and uncertainties, investors should not place undue
reliance on forward-looking statements as predictive of future
results.
Important factors, risks and uncertainties include:
|
|
|
|
|
fluctuations in general business cycles for commercial aircraft,
military aircraft, space and defense products, industrial
capital goods and medical devices;
|
|
|
|
our dependence on government contracts that may not be fully
funded or may be terminated;
|
|
|
|
our dependence on certain major customers, such as The Boeing
Company and Lockheed Martin, for a significant percentage of our
sales;
|
|
|
|
delays by our customers in the timing of introducing new
products, which may affect our earnings and cash flow;
|
|
|
|
the possibility that the demand for our products may be reduced
if we are unable to adapt to technological change;
|
|
|
|
intense competition, which may require us to lower prices or
offer more favorable terms of sale;
|
|
|
|
our indebtedness, which could limit our operational and
financial flexibility;
|
|
|
|
the possibility that new product and research and development
efforts may not be successful, which could reduce our sales and
profits;
|
|
|
|
increased cash funding requirements for pension plans, which
could occur in future years based on assumptions used for our
defined benefit pension plans, including returns on plan assets
and discount rates;
|
|
|
|
a write-off of all or part of our goodwill or intangible assets,
which could adversely affect our operating results and net worth
and cause us to violate covenants in our bank agreements;
|
|
|
|
the potential for substantial fines and penalties or suspension
or debarment from future contracts in the event we do not comply
with regulations relating to defense industry contracting;
|
|
|
|
the potential for cost overruns on development jobs and
fixed-price contracts and the risk that actual results may
differ from estimates used in contract accounting;
|
S-13
|
|
|
|
|
the possibility that our subcontractors may fail to perform
their contractual obligations, which may adversely affect our
contract performance and our ability to obtain future business;
|
|
|
|
our ability to successfully identify and consummate
acquisitions, and integrate the acquired businesses and the
risks associated with acquisitions, including that the acquired
businesses do not perform in accordance with our expectations,
and that we assume unknown liabilities in connection with
acquired businesses for which we are not indemnified;
|
|
|
|
our dependence on our management team and key personnel;
|
|
|
|
the possibility of a catastrophic loss of one or more of our
manufacturing facilities;
|
|
|
|
the possibility that future terror attacks, war or other civil
disturbances could negatively impact our business;
|
|
|
|
that our operations in foreign countries could expose us to
political risks and adverse changes in local, legal, tax and
regulatory schemes;
|
|
|
|
the possibility that government regulation could limit our
ability to sell our products outside the United States;
|
|
|
|
product quality or patient safety issues with respect to our
medical devices business that could lead to product recalls,
withdrawal from certain markets, delays in the introduction of
new products, sanctions, litigation, declining sales or actions
of regulatory bodies and government authorities;
|
|
|
|
the impact of product liability claims related to our products
used in applications where failure can result in significant
property damage, injury or death and in damage to our reputation;
|
|
|
|
changes in medical reimbursement rates of insurers to medical
service providers, which could affect sales of our medical
products;
|
|
|
|
the possibility that litigation results may be unfavorable to us;
|
|
|
|
our ability to adequately enforce our intellectual property
rights and the possibility that third parties will assert
intellectual property rights that prevent or restrict our
ability to manufacture, sell, distribute or use our products or
technology;
|
|
|
|
foreign currency fluctuations in those countries in which we do
business and other risks associated with international
operations;
|
|
|
|
the cost of compliance with environmental laws;
|
|
|
|
the risk of losses resulting from maintaining significant
amounts of cash and cash equivalents at financial institutions
that are in excess of amounts insured by governments;
|
|
|
|
the inability to modify, to refinance or to utilize amounts
presently available to us under our credit facilities given
uncertainties in the credit markets;
|
|
|
|
our ability to meet the restrictive covenants under our credit
facilities since a breach of any of these covenants could result
in a default under our credit agreements; and
|
|
|
|
our customers inability to continue operations or to pay
us due to adverse economic conditions or their inability to
access available credit.
|
S-14
USE OF
PROCEEDS
We estimate that the net proceeds we will receive from our sale
of Class A common stock in this offering will be
approximately $ million, or
$ million if the underwriters
exercise their overallotment option in full, based on an
offering price of $ per share and
after deducting the underwriters fee and estimated
offering expenses. We will use the net proceeds from this
offering to repay a portion of the outstanding indebtedness
under the revolving credit facility portion of our bank credit
facility that was borrowed to pay for our acquisition of the
flight control actuation business of GE Aviation Systems, an
operating unit of General Electric Company. This amount may be
reborrowed for general corporate purposes, including other
acquisitions.
Interest on borrowings under the bank credit facility, at our
election, are at the London Interbank Offered Rate, or LIBOR,
plus a spread, or the prime rate. The spread on LIBOR based
borrowings is determined by a leverage ratio, with the spread at
June 27, 2009 at 200 basis points and at
September 24, 2009 at 225 basis points. The weighted
average interest rate on borrowings under this facility at
June 27, 2009 was 2.5% per annum. On June 27, 2009,
there was $398 million outstanding under our bank credit
facility, consisting of $18 million of prime rate
borrowings and $380 million of LIBOR based borrowings.
S-15
CAPITALIZATION
This table presents our capitalization as of June 27, 2009:
|
|
|
|
|
on an actual basis; and
|
|
|
|
on an as adjusted basis to reflect the sale by us of
2,500,000 shares of Class A common stock in this
offering, based on a public offering price of
$ per share.
|
The following table should be read in conjunction with Use
of Proceeds and our consolidated financial statements and
related notes incorporated by reference in this prospectus
supplement and the accompanying prospectus.
In this table, shareholders equity excludes:
|
|
|
|
|
1,699,886 shares of Class A common stock issuable upon
exercise of outstanding stock options under our stock option
plans as of June 27, 2009 at a weighted average exercise
price of $26.27 per share;
|
|
|
|
13,192 shares of Class A common stock reserved and
available for future issuance under our stock option plans as of
June 27, 2009;
|
|
|
|
Shares of Class A common stock available under employee
benefit plans for future grants; and
|
|
|
|
up to 375,000 shares of Class A common stock that may
be issued to the underwriters upon exercise of their
overallotment option.
|
|
|
|
|
|
|
|
|
|
|
|
June 27, 2009
|
|
|
|
Actual
|
|
|
As Adjusted
|
|
|
|
(In thousands)
|
|
|
Short-Term Debt:
|
|
|
|
|
|
|
|
|
Notes payable
|
|
$
|
28,497
|
|
|
$
|
28,497
|
|
Current installments of long-term debt
|
|
|
10,170
|
|
|
|
10,170
|
|
|
|
|
|
|
|
|
|
|
Total short-term debt
|
|
$
|
38,667
|
|
|
$
|
38,667
|
|
|
|
|
|
|
|
|
|
|
Long-Term Debt:
|
|
|
|
|
|
|
|
|
Bank credit facility:
|
|
|
|
|
|
|
|
|
Revolving credit facility
|
|
$
|
397,810
|
|
|
$
|
|
|
International and other U.S. loan agreements
|
|
|
12,981
|
|
|
|
12,981
|
|
Obligations under capital leases
|
|
|
1,155
|
|
|
|
1,155
|
|
Senior subordinated notes
|
|
|
380,635
|
|
|
|
380,635
|
|
|
|
|
|
|
|
|
|
|
Total long-term debt
|
|
$
|
792,581
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders Equity:
|
|
|
|
|
|
|
|
|
Class A Common Stock, $1.00 par value;
100,000,000 shares authorized; 40,795,623 shares
issued and 38,491,924 shares outstanding on an actual basis
and 43,295,623 shares issued and 40,991,924 shares
outstanding on an adjusted basis
|
|
|
40,796
|
|
|
|
43,296
|
|
Class B Common Stock, $1.00 par value;
20,000,000 shares authorized; 7,809,090 shares issued
and 4,114,678 shares outstanding
|
|
|
7,809
|
|
|
|
7,809
|
|
Additional paid-in capital
|
|
|
306,926
|
|
|
|
|
|
Retained earnings
|
|
|
757,452
|
|
|
|
757,452
|
|
Treasury shares
|
|
|
(47,733
|
)
|
|
|
(47,733
|
)
|
Stock employee compensation trust
|
|
|
(9,925
|
)
|
|
|
(9,925
|
)
|
Accumulated other comprehensive income
|
|
|
1,114
|
|
|
|
1,114
|
|
|
|
|
|
|
|
|
|
|
Total shareholders equity
|
|
|
1,056,439
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
1,887,687
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
S-16
PRICE
RANGE OF CLASS A COMMON STOCK
Our Class A common stock trades on the New York Stock
Exchange under the symbol MOG.A. The following table sets forth
for the quarters indicated the high and low sales prices as
reported by the New York Stock Exchange.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
Fiscal 2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
40.50
|
|
|
$
|
33.91
|
|
Second Quarter
|
|
|
41.74
|
|
|
|
35.03
|
|
Third Quarter
|
|
|
45.16
|
|
|
|
40.22
|
|
Fourth Quarter
|
|
|
49.42
|
|
|
|
37.20
|
|
Fiscal 2008
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
49.19
|
|
|
$
|
41.18
|
|
Second Quarter
|
|
|
48.24
|
|
|
|
38.79
|
|
Third Quarter
|
|
|
46.37
|
|
|
|
37.46
|
|
Fourth Quarter
|
|
|
56.47
|
|
|
|
35.30
|
|
Fiscal 2009
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
43.36
|
|
|
$
|
24.00
|
|
Second Quarter
|
|
|
39.58
|
|
|
|
17.90
|
|
Third Quarter
|
|
|
28.57
|
|
|
|
21.50
|
|
Fourth Quarter (through September 24, 2009)
|
|
|
33.17
|
|
|
|
22.93
|
|
The closing sale price of our Class A common stock on
September 24, 2009 as reported by the New York Stock
Exchange was $31.41 per share. As of September 24, 2009,
there were 1,073 record holders of our Class A common stock
and 478 record holders of our Class B common stock.
We intend to retain our earnings to finance the expansion of our
business and do not anticipate paying cash dividends on our
common stock in the foreseeable future. Any future determination
regarding cash dividends will be made by our board of directors
and will depend upon our earnings, financial condition, capital
requirements, any limitations in our financing agreements, and
other factors deemed relevant by the board. Payment of cash
dividends is permitted by our bank credit facility, with a
limitation on the aggregate amount of dividends which may be
paid to shareholders.
S-17
CERTAIN
U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS
FOR NON-U.S.
HOLDERS
The following discussion summarizes certain U.S. federal
income and estate tax considerations that may be relevant to the
purchase, ownership and disposition of our Class A common
stock. Except where noted, this summary deals only with shares
of Class A common stock that are held as a capital asset
(generally for investment purposes) by a beneficial owner that
is a
Non-U.S. Holder
(as defined below) who purchases Class A common stock in
this offering.
A
Non-U.S. Holder
means a person who owns Class A common stock and who is
not, for U.S. federal income tax purposes, any of the
following:
|
|
|
|
|
an individual who is a U.S. citizen or U.S. resident
alien;
|
|
|
|
a corporation, or other entity taxable as a corporation for
U.S. federal income tax purposes, that was created or
organized in or under the laws of the United States, any state
thereof or the District of Columbia;
|
|
|
|
an estate whose income is subject to U.S. federal income
taxation regardless of its source; or
|
|
|
|
a trust (i) if a court within the United States is able to
exercise primary supervision over the administration of the
trust and one or more U.S. persons have the authority to
control all substantial decisions of the trust, or
(ii) that has a valid election in effect under applicable
U.S. Treasury regulations to be treated as a
U.S. person.
|
If a partnership (including for this purpose any entity treated
as a partnership for U.S. federal income tax purposes) is a
holder of our Class A common shares, the treatment of a
partner in the partnership generally will depend on the status
of the partner and the activities of the partnership.
Partnership and partners in such partnership should consult
their own tax advisors about the U.S. federal tax
consideration of owning and disposing of our Class A common
shares.
This summary is based upon provisions of the Internal Revenue
Code of 1986, as amended, (the Code), applicable
Treasury regulations (proposed, temporary and final), judicial
authority and administrative interpretations as of the date
hereof. Those authorities may be changed, possibly with
retroactive effect, so as to result in U.S. federal income
and estate tax consequences different from those summarized
below. This summary also does not address all aspects of
U.S. federal income and estate taxes and does not deal with
foreign, state, local or other tax considerations that may be
relevant to
Non-U.S. Holders
in light of their personal circumstances (such as the
alternative minimum tax). In addition, it does not address all
U.S. federal income tax considerations for certain
categories of investors that may be subject to special rules
under the U.S. federal income tax laws, including, but not
limited to, certain U.S. expatriates, brokers, traders and
dealers in securities, tax exempt organizations, and foreign
governments and agencies. We cannot assure you that a change in
the law will not alter significantly the tax considerations that
we describe in this summary. We cannot assure you that the
Internal Revenue Service (IRS) will not challenge
one or more of the consequences described herein, and we have
not obtained, nor do we intend to obtain, a ruling from the IRS
or an opinion of counsel with respect to the U.S. federal
income and estate tax consequence of purchasing, owning, or
disposing of the Class A common shares.
The following discussion of certain U.S. federal tax
considerations is for general information only and is not
intended as tax advice to any particular investor. If you are
considering the purchase of our Class A common stock, you
should consult your own tax advisor concerning your particular
situation and the U.S. federal income and estate tax
consequences to you of purchasing, holding, and disposing of our
Class A common stock, as well as potential effects of
changes in applicable tax law and the consequences to you
arising under the laws of any other taxing jurisdiction.
Considerations
for Non-U.S. Holders
Dividends
As explained in Price Range of Class A Common Stock,
we do not anticipate paying distributions on our Class A common
stock in the foreseeable future. In the event we make
distributions, gross amount of any such distributions paid to a
Non-U.S. Holder
of our Class A common stock will be considered dividends to
the extent paid out of our current or accumulated earnings and
profits, as determined under U.S. federal income tax
principles. If a
S-18
distribution exceeds our current and accumulated earnings and
profits, the excess will be treated as a tax-free return of the
Non-U.S. Holders
investment to the extent of the
Non-U.S. Holders
adjusted tax basis in our Class A common stock, and any
remaining excess will be treated as capital gain. Dividends
generally will be subject to U.S. federal income tax at a
30% rate or such lower rate as may be specified by an applicable
income tax treaty unless the dividends are effectively connected
with a U.S. trade or business, as described below. See
Income or Gain Effectively Connected with a
U.S. Trade or Business. The 30% tax must be withheld
by us unless a Non-U.S. Holder provides us with valid
documentation (described below) that the income is effectively
connected to a U.S. trade or business or a reduced rate
applies under an applicable tax treaty.
A
Non-U.S. Holder
of our Class A common stock who wishes to claim the benefit
of an applicable treaty rate for dividends will be required to
furnish to us or certain other intermediaries required to
withhold a valid IRS
Form W-8BEN
(or successor form or an acceptable substitute form) on which
the holder certifies under penalty of perjury that such holder
is not a U.S. person as defined under the Code and is
eligible for the treaty benefits, or, if our Class A common
stock is held through certain foreign intermediaries, such
Non-U.S. Holder will be required to satisfy the relevant
certification requirements of applicable U.S. Treasury
regulations. Special certification and other requirements apply
to certain
Non-U.S. Holders
that are pass-through entities rather than corporations or
individuals.
A
Non-U.S. Holder
of our Class A common stock eligible for a reduced rate of
U.S. withholding tax pursuant to an income tax treaty may
obtain a refund of any excess amounts withheld by timely filing
an appropriate refund claim with the IRS.
Disposition
of Class A Common Stock
Any gain realized on the sale, redemption, exchange or other
taxable disposition of our Class A common stock generally
will not be subject to U.S. federal income tax (and
generally no tax will be withheld) unless:
|
|
|
|
|
the gain is effectively connected with a trade or business of
the
Non-U.S. Holder
in the United States (and, in the case of an applicable income
tax treaty, is attributable to a U.S. permanent
establishment of the
Non-U.S. Holder);
|
|
|
|
the
Non-U.S. Holder
is an individual who is present in the United States for
183 days or more in the taxable year of that disposition,
and certain other conditions are met; or
|
|
|
|
we are or have been a United States real property holding
corporation for U.S. federal income tax purposes at
any time during a look-back period, which is the shorter of
(i) the five-year period preceding such disposition and
(ii) the Non-U.S. Holders holding period in the
common stock; the
Non-U.S. Holder
beneficially owns, or has owned, at sometime during the
look-back period more than 5% of the total fair market value of
our Class A common stock; and our Class A common stock
ceases to be traded on an established securities market prior to
the beginning of the calendar year in which the sale or
disposition occurs.
|
A
Non-U.S. Holder
described in the first bullet point immediately above will be
subject to tax as described below. See Income on Gain
Effectively Connected with a U.S. Trade or Business.
An individual
Non-U.S. Holder
described in the second bullet point immediately above will be
subject to a flat 30% tax on the gain derived from the sale,
which may be offset by U.S. source capital losses, even
though the individual is not considered a resident of the United
States.
We believe we are not, and we do not anticipate becoming, a
United States real property holding corporation for
U.S. federal income tax purposes. Generally, a corporation
is a United States real property holding corporation
if the fair market value of its U.S. real property interests
equals or exceeds 50% of the sum of the fair market value of its
worldwide real property interests and its other assets used or
held for use in a trade or business.
Income or
Gain Effectively Connected with a U.S. Trade or
Business
If any dividends or gain from the sale, exchange or other
taxable disposition of the Class A common stock is
effectively connected with a U.S. trade or business
conducted by a
Non-U.S. Holder
(and, in the case of an applicable treaty, attributable to the
Non-U.S. Holders
permanent establishment in the United States), then the
S-19
income or gain will be subject to the U.S. federal income
tax at regular graduated income tax rates, but will not be
subject to withholding if certain certification requirements are
met. A
Non-U.S. Holder
can generally meet the certification requirements by providing a
properly executed IRS
Form W-8ECI
or successor form or appropriate substitute form to us. If a
Non-U.S. Holder
is a corporation, the portion of the earnings and profits that
is effectively connected with the corporations
U.S. trade or business (and, in the case of an applicable
tax treaty, attributable to the
Non-U.S. Holders
permanent establishment in the United States) also may be
subject to an additional branch profits tax at a 30%
rate, although an applicable tax treaty may provide for a lower
rate.
Information
Reporting and Backup Withholding
We must report annually to the IRS and to each
Non-U.S. Holder
the amount of dividends paid to such holder and the tax withheld
with respect to such dividends, regardless of whether
withholding was required. Copies of the information returns
reporting such dividends and withholding may also be made
available to the tax authorities in the country in which the
Non-U.S. Holder
resides under the provisions of an applicable income tax treaty
or information sharing agreement.
A
Non-U.S. Holder
will be subject to backup withholding for dividends paid to such
holder unless such holder certifies under penalty of perjury
that it is a
Non-U.S. Holder
(and the payor does not have actual knowledge or reason to know
that such holder is a United States person as defined under the
Code), or such holder otherwise establishes an exemption. See
discussion of certification requirements under
Dividends above.
Payment of the proceeds of a sale of our Class A common
stock effected by the U.S. office of a U.S. or foreign
broker will be subject to information reporting requirements and
backup withholding unless you properly certify under penalties
of perjury as to your foreign status and certain other
conditions are met or you otherwise establish an exemption.
Information reporting requirements and backup withholding
generally will not apply to any payment of the proceeds of a
sale effected outside the United States by a foreign office of a
broker. However, unless such a broker has documentary evidence
in its records that you are a
Non-U.S. Holder
and certain other conditions are met, or you otherwise establish
an exemption, information reporting will apply to a payment of
the proceeds of the sale of a note effected outside the United
States by such a broker if it:
|
|
|
|
|
is a United States person;
|
|
|
|
derives 50% or more of its gross income for certain periods from
the conduct of a trade or business in the United States;
|
|
|
|
is a controlled foreign corporation for U.S. federal income
tax purposes; or
|
|
|
|
is a foreign partnership that, at any time during its taxable
year, has more than 50% of its income or capital interests owned
by U.S. persons or is engaged in the conduct of a
U.S. trade or business.
|
Backup withholding is not an additional tax. Any amount withheld
under the backup withholding rules may be credited against your
U.S. federal income tax liability and any excess may be
refundable if the proper information is provided to the IRS on a
timely basis.
Prospective Non-U.S. Holders should consult their own tax
advisors concerning the application of information reporting and
backup withholding rules.
Federal
Estate Tax
The value of shares of our Class A common stock treated for
U.S. estate tax purposes as owned by an individual
Non-U.S. Holder
at the time of death will be included in such individuals
gross estate for U.S. federal estate tax purposes, and may
be subject to U.S. federal estate tax unless an applicable
estate tax treaty provides otherwise.
S-20
UNDERWRITING
We and the underwriters for the offering named below have
entered into an underwriting agreement with respect to the
Class A common stock being offered. Subject to the terms
and conditions of the underwriting agreement, each underwriter
has severally agreed to purchase from us the number of shares of
our Class A common stock set forth opposite its name below.
Cowen and Company, LLC is the representative of the underwriters.
|
|
|
|
|
Underwriter
|
|
Number of Shares
|
|
|
Cowen and Company, LLC
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,500,000
|
|
|
|
|
|
|
The underwriting agreement provides that the obligations of the
underwriters are conditional and may be terminated at their
discretion based on their assessment of the state of the
financial markets. The obligations of the underwriters may also
be terminated upon the occurrence of the events specified in the
underwriting agreement. The underwriters have agreed, severally
and not jointly, to purchase all of the shares sold under the
underwriting agreement if any of these shares are purchased,
other than those shares covered by the overallotment option
described below. If an underwriter defaults, the underwriting
agreement provides that the purchase commitments of the
non-defaulting underwriters may be increased or the underwriting
agreement may be terminated.
We have agreed to indemnify the underwriters against specified
liabilities, including liabilities under the Securities Act of
1933, and to contribute to payments the underwriters may be
required to make in respect thereof.
The underwriters are offering the shares, subject to prior sale,
when, as and if issued to and accepted by them, subject to
approval of legal matters by their counsel and other conditions
specified in the underwriting agreement. The underwriters
reserve the right to withdraw, cancel or modify offers to the
public and to reject orders in whole or in part.
All sales of shares in the United States will be made by or
through U.S. registered broker-dealers as permitted by the
applicable regulations.
We will deliver the shares of Class A common stock against
payment therefore on , 2009, which
is the second scheduled business day following the date of this
prospectus supplement, such settlement cycle being referred to
as T+2. Under
Rule 15c6-1
of the Exchange Act, trades in the secondary market generally
are required to settle in three business days, unless the
parties to any such trade expressly agree otherwise. Purchasers
of shares of Class A common stock should be aware that the
ability to settle secondary market trades of such shares
effected on the date of pricing and the next succeeding business
day may be affected by the T+2 settlement. Purchasers of the
shares of Class A common stock who wish to trade any such
shares on the date of pricing should consult their own advisor.
Overallotment Option to Purchase Additional
Shares. We have granted to the underwriters
an option to purchase up to additional shares of Class A
common stock at the public offering price, less the underwriting
discount. This option is exercisable for a period of
30 days. The underwriters may exercise this option solely
for the purpose of covering overallotments, if any, made in
connection with the sale of Class A common stock offered
hereby. To the extent that the underwriters exercise this
option, the underwriters will purchase additional shares from us
in approximately the same proportion as shown in the table above.
Discounts and Commissions. The
following table shows the public offering price, underwriting
discount and proceeds, before expenses to us. These amounts are
shown assuming both no exercise and full exercise of the
underwriters option to purchase additional shares.
S-21
We estimate that the total expenses of the offering, excluding
underwriting discount, will be approximately
$ and are payable by us.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
Without
|
|
|
With
|
|
|
|
Per Share
|
|
|
Overallotment
|
|
|
Overallotment
|
|
|
Public offering price
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Underwriting discount
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Proceeds, before expenses, to Company
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
The underwriters propose to offer the shares of Class A
common stock to the public at the public offering price set
forth on the cover of this prospectus. The underwriters may
offer the shares of Class A common stock to securities
dealers at the public offering price less a concession not in
excess of $ per share. The
underwriters may allow, and the dealers may reallow, a discount
not in excess of $ per share to
other dealers. If all of the shares are not sold at the public
offering price, the underwriters may change the offering price
and other selling terms.
Discretionary Accounts. The
underwriters do not intend to confirm sales of the shares to any
accounts over which they have discretionary authority.
Stabilization. In connection with this
offering, the underwriters may engage in stabilizing
transactions, overallotment transactions, syndicate covering
transactions, penalty bids and purchases to cover positions
created by short sales.
|
|
|
|
|
Stabilizing transactions permit bids to purchase shares of
common stock so long as the stabilizing bids do not exceed a
specified maximum, and are engaged in for the purpose of
preventing or retarding a decline in the market price of the
common stock while the offering is in progress.
|
|
|
|
Overallotment transactions involve sales by the underwriters of
shares of common stock in excess of the number of shares the
underwriters are obligated to purchase. This creates a syndicate
short position which may be either a covered short position or a
naked short position. In a covered short position, the number of
shares over-allotted by the underwriters is not greater than the
number of shares that they may purchase in the overallotment
option. In a naked short position, the number of shares involved
is greater than the number of shares in the overallotment
option. The underwriters may close out any short position by
exercising their overallotment option
and/or
purchasing shares in the open market.
|
|
|
|
Syndicate covering transactions involve purchases of common
stock in the open market after the distribution has been
completed in order to cover syndicate short positions. In
determining the source of shares to close out the short
position, the underwriters will consider, among other things,
the price of shares available for purchase in the open market as
compared with the price at which they may purchase shares
through exercise of the overallotment option. If the
underwriters sell more shares than could be covered by exercise
of the overallotment option and, therefore, have a naked short
position, the position can be closed out only by buying shares
in the open market. A naked short position is more likely to be
created if the underwriters are concerned that after pricing
there could be downward pressure on the price of the shares in
the open market that could adversely affect investors who
purchase in the offering.
|
|
|
|
Penalty bids permit the representative to reclaim a selling
concession from a syndicate member when the common stock
originally sold by that syndicate member is purchased in
stabilizing or syndicate covering transactions to cover
syndicate short positions.
|
These stabilizing transactions, syndicate covering transactions
and penalty bids may have the effect of raising or maintaining
the market price of our common stock or preventing or retarding
a decline in the market price of our common stock. As a result,
the price of our common stock in the open market may be higher
than it would otherwise be in the absence of these transactions.
Neither we nor the underwriters make any representation or
prediction as to the effect that the transactions described
above may have on the price of our common stock. These
transactions may be effected in the
over-the-counter
market or otherwise and, if commenced, may be discontinued at
any time.
S-22
Lock-Up
Agreements. Pursuant to certain
lock-up
agreements, we and our executive officers, directors and certain
of our other stockholders, have agreed, subject to certain
exceptions, not to offer, sell, assign, transfer, pledge,
contract to sell, or otherwise dispose of or announce the
intention to otherwise dispose of, or enter into any swap, hedge
or similar agreement or arrangement that transfers, in whole or
in part, the economic consequence of ownership of, directly or
indirectly, or make any demand or request or exercise any right
with respect to the registration of, or file with the SEC a
registration statement under the Securities Act relating to, any
common stock or securities convertible into or exchangeable or
exercisable for any common stock without the prior written
consent of Cowen and Company, LLC, for a period of 90 days
after the date of the pricing of the offering. The
90-day
restricted period will be automatically extended if
(i) during the last 17 days of the
90-day
restricted period we issue an earnings release or material news
or a material event relating to us occurs or (ii) prior to
the expiration of the
90-day
restricted period, we announce that we will release earnings
results or become aware that material news or a material event
will occur during the
16-day
period beginning on the last day of the
90-day
restricted period, in either of which case the restrictions
described above will continue to apply until the expiration of
the 18-day
period beginning on the issuance of the earnings release or the
occurrence of the material news or material event.
This lock-up
provision applies to common stock and to securities convertible
into or exchangeable or exercisable for common stock. It also
applies to common stock owned now or acquired later by the
person executing the agreement or for which the person executing
the agreement later acquires the power of disposition. The
exceptions permit us, among other things and subject to
restrictions, to: (a) issue common stock or options
pursuant to employee benefit plans, (b) issue common stock
upon exercise of outstanding options or warrants, or
(c) file registration statements on
Form S-8.
In addition, the
lock-up
provision will not restrict broker-dealers from engaging in
market making and similar activities conducted in the ordinary
course of their business.
United Kingdom. Each of the
underwriters has represented and agreed that:
|
|
|
|
|
it has not made or will not make an offer of the securities to
the public in the United Kingdom within the meaning of
section 102B of the Financial Services and Markets Act 2000
(as amended) (FSMA) except to legal entities which are
authorized or regulated to operate in the financial markets or,
if not so authorized or regulated, whose corporate purpose is
solely to invest in securities or otherwise in circumstances
which do not require the publication by us of a prospectus
pursuant to the Prospectus Rules of the Financial Services
Authority (FSA);
|
|
|
|
it has only communicated or caused to be communicated and will
only communicate or cause to be communicated an invitation or
inducement to engage in investment activity (within the meaning
of section 21 of FSMA) to persons who have professional
experience in matters relating to investments falling within
Article 19(5) of the Financial Services and Markets Act
2000 (Financial Promotion) Order 2005 or in circumstances in
which section 21 of FSMA does not apply to us; and
|
|
|
|
it has complied with and will comply with all applicable
provisions of FSMA with respect to anything done by it in
relation to the securities in, from or otherwise involving the
United Kingdom.
|
Switzerland. The securities will not be
offered, directly or indirectly, to the public in Switzerland
and this prospectus does not constitute a public offering
prospectus as that term is understood pursuant to
article 652a or 1156 of the Swiss Federal Code of
Obligations.
European Economic Area. In relation to
each Member State of the European Economic Area (Iceland, Norway
and Lichtenstein in addition to the member states of the
European Union) that has implemented the Prospectus Directive
(each, a Relevant Member State), each underwriter has
represented and agreed that with effect from and including the
date on which the Prospectus Directive is implemented in that
Relevant Member State (the Relevant Implementation Date) it has
not made and will not make an offer of the securities to the
public in that Relevant Member State prior to the publication of
a prospectus in relation to the securities that has been
approved by the competent authority in that Relevant Member
State or, where appropriate, approved in another Relevant Member
State and notified to the competent authority in that Relevant
Member State, all in accordance with the Prospectus Directive,
except that it may, with effect from and including the Relevant
Implementation Date, make an offer of the securities to the
public in that Relevant Member State at any time:
S-23
|
|
|
|
|
to legal entities which are authorized or regulated to operate
in the financial markets or, if not so authorized or regulated,
whose corporate purpose is solely to invest in securities;
|
|
|
|
to any legal entity which has two or more of (1) an average
of at least 250 employees during the last financial year;
(2) a total balance sheet of more than 43,000,000 and
(3) an annual net turnover of more than 50,000,000,
as shown in its last annual or consolidated accounts;
|
|
|
|
in any other circumstances which do not require the publication
by the issuer of a prospectus pursuant to Article 3 of the
Prospectus Directive.
|
Each person in a Relevant Member State who receives any
communication in respect of, or who acquires any securities
under, the offer contemplated in this prospectus will be deemed
to have represented, warranted and agreed to and with us and
each underwriter that:
|
|
|
|
|
it is a qualified investor within the meaning of the law in that
Relevant Member State implementing Article 2(1)(e) of the
Prospectus Directive; and
|
|
|
|
in the case of any securities acquired by it as a financial
intermediary, as that term is used in Article 3(2) of the
Prospectus Directive, (1) the securities acquired by it in
the offer have not been acquired on behalf of, nor have they
been acquired with a view to their offer or resale to, persons
in any Relevant Member State other than qualified investors, as
that term is defined in the Prospectus Directive, or in
circumstances in which the prior consent of the representative
of the underwriters has been given to the offer or resale; or
(2) where securities have been acquired by it on behalf of
persons in any Relevant Member State other than qualified
investors, the offer of those securities to it is not treated
under the Prospectus Directive as having been made to such
persons.
|
For the purposes of the provisions in the two immediately
preceding paragraphs, the expression an offer of the
securities to the public in relation to the securities in
any Relevant Member State means the communication in any form
and by any means of sufficient information on the terms of the
offer and the securities to be offered so as to enable an
investor to decide to purchase or subscribe for the securities,
as the same may be varied in that Relevant Member State by any
measure implementing the Prospectus Directive in that Relevant
Member State, and the expression Prospectus
Directive means Directive 2003/71/EC and includes any
relevant implementing measure in each Relevant Member State.
Electronic Offer, Sale and Distribution of
Shares. A prospectus in electronic format may
be made available on the websites maintained by one or more of
the underwriters or selling group members, if any, participating
in this offering and one or more of the underwriters
participating in this offering may distribute prospectuses
electronically. The representatives may agree to allocate a
number of shares to underwriters and selling group members for
sale to their online brokerage account holders. Internet
distributions will be allocated by the underwriters and selling
group members that will make internet distributions on the same
basis as other allocations. Other than the prospectus in
electronic format, the information on these websites is not part
of this prospectus or the registration statement of which this
prospectus forms a part, has not been approved or endorsed by us
or any underwriter in its capacity as underwriter, and should
not be relied upon by investors.
Other Relationships. Certain of the
underwriters and their affiliates have provided, and may in the
future provide, various investment banking, commercial banking
and other financial services for us and our affiliates for which
they are received, and may in the future receive, customary
fees. In particular certain of the underwriters or their
affiliates may be lenders under our bank credit facility. The
proceeds from this offering will be used to repay a portion of
the outstanding indebtedness under the revolving facility
portion of our bank credit facility. See Use of
Proceeds. Cowen and Company, LLC has agreed to reimburse
certain of our expenses and other costs relating to this
offering.
Conflicts of Interest. As described in
Use of Proceeds, some of the net proceeds of this
offering will be used to repay a portion of the outstanding
indebtedness under our revolving credit facility portion of our
bank credit facility. Because more than 5% of the proceeds of
this offering, not including underwriting compensation, may be
received by one of the underwriters in this offering or by one
of their affiliates, this offering is being conducted in
compliance with NASD Rule 2720, as administered by the
Financial Industry Regulatory Authority (FINRA).
Pursuant to that rule, the appointment of a qualified
independent underwriter is not necessary in connection with this
offering, as the offering is of a class of equity securities for
which a bona fide public market, as defined by FINRA
rules, exists.
S-24
LEGAL
MATTERS
The validity of the shares of Class A common stock offered
by this prospectus supplement and accompanying prospectus will
be passed upon for us by Hodgson Russ LLP, Buffalo, New York.
John B. Drenning, the corporate secretary of Moog, is a partner
in Hodgson Russ LLP. He and other attorneys in that firm
beneficially own an aggregate of approximately
10,500 shares of Class A common stock. Certain legal
matters in connection with the offering will be passed upon for
the underwriters by Shearman & Sterling LLP, New York,
New York.
WHERE YOU
CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. Our SEC filings are
available to the public over the Internet from the SECs
web site at
http://www.sec.gov.
You may also read and copy any document we file at the
SECs public reference room located at
100 F Street, NE, Washington, D.C. 20549. Please
call the SEC at
1-800-SEC-0330
for further information on the public reference room and their
copy charges.
The SEC allows us to incorporate by reference in
this prospectus supplement and the accompanying prospectus the
information in documents filed with it. This means that we can
disclose important information to you by referring you to these
documents. The information incorporated by reference is
considered to be a part of this prospectus supplement and the
accompanying prospectus, and information in documents that we
file later with the SEC will automatically update and supersede
information contained in documents filed earlier with the SEC or
contained in this prospectus supplement and the accompanying
prospectus.
We incorporate by reference in this prospectus supplement and
the accompanying prospectus the documents listed below and any
future filings that we may make with the SEC under
Sections 13(a), 13(c), 14 or 15(d) of the Securities
Exchange Act of 1934 prior to the termination of this offering.
These additional documents include periodic reports, such as
annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K
(other than information furnished under Items 2.02 and
7.01, which is deemed not to be incorporated by reference in
this prospectus). You should review these filings as they may
disclose a change in our business, prospects, financial
condition or other affairs after the date of this prospectus.
The information we file later with the SEC under
Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act and
before the termination of this offering will automatically
update and supersede previous information included or
incorporated by reference in this prospectus supplement or the
accompanying prospectus.
This prospectus supplement and the accompanying prospectus
incorporates by reference the documents listed below that we
have filed with the SEC but have not been included or delivered
with this document:
|
|
|
|
|
Our Annual Report on
Form 10-K
for the year ended September 27, 2008;
|
|
|
|
Our Quarterly Reports on
Form 10-Q
for the quarters ended December 27, 2008, March 28,
2009 and June 27, 2009; and
|
|
|
|
Our Current Reports on
Form 8-K
filed October 3, 2008, October 7, 2008,
October 30, 2008 (but only with respect to the disclosure
under Item 8.01 included in such report), November 14,
2008, December 31, 2008, January 23, 2009,
February 2, 2009, February 17, 2009, March 2,
2009, June 1, 2009, June 26, 2009, September 4,
2009, September 21, 2009 and September 28, 2009.
|
S-25
You may request a copy of these documents, at no cost to you, by
writing or telephoning us at:
Moog Inc.
Seneca St. at Jamison Rd.
Corporate Offices
East Aurora, NY 14052
Attention: Investor Relations
(716) 652-2000
Any statement made in this prospectus supplement and the
accompanying prospectus concerning the contents of any contract,
agreement or other document is only a summary of the actual
document. You may obtain a copy of any document summarized in
this prospectus supplement and the accompanying prospectus at no
cost by writing to or telephoning us at the address and
telephone number given above. Each statement regarding a
contract, agreement or other document is qualified in its
entirety by reference to the actual document.
S-26
PROSPECTUS
MOOG INC.
CLASS A
COMMON STOCK
This prospectus provides you with a general description of the
Class A common stock that we may offer from time to time.
Each time we sell Class A common stock, we will provide a
prospectus supplement that will contain specific information
about the terms of the sale and that may add to or update the
information in this prospectus. You should read this prospectus
and the applicable prospectus supplement carefully before you
invest.
This prospectus may not be used to sell our Class A common stock
unless it is accompanied by a prospectus supplement or other
offering material.
We may offer the Class A common stock in amounts, at prices
and on terms determined by market conditions at the time of the
offering. We may sell the Class A common stock through
agents we select or through underwriters and dealers we select.
If we use agents, underwriters or dealers to sell the
Class A common stock, we will name them and describe their
compensation in a prospectus supplement.
Our Class A common stock is listed on the New York Stock
Exchange under the trading symbol MOG.A.
Our business and investment in our Class A common stock
involve significant risks. These risks are described under the
caption Risk Factors beginning on page 10 of
this prospectus and in our periodic reports filed with the
Securities and Exchange Commission, the applicable prospectus
supplement and other offering material.
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal
offense.
This prospectus is dated
September 28, 2009.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
1
|
|
|
|
|
1
|
|
|
|
|
2
|
|
|
|
|
5
|
|
|
|
|
10
|
|
|
|
|
12
|
|
|
|
|
13
|
|
|
|
|
14
|
|
|
|
|
15
|
|
|
|
|
16
|
|
|
|
|
16
|
|
ABOUT
THIS PROSPECTUS
This prospectus is part of a registration statement that we,
Moog Inc., filed with the Securities Exchange Commission, or the
SEC, using a shelf registration process. Under this
shelf registration process, we may, from time to time, sell
shares of Class A common stock described in the prospectus,
in one or more offerings. This prospectus provides you with a
general description of the Class A common stock we may
offer. Each time we sell Class A common stock, we will
provide a prospectus supplement, or more than one prospectus
supplement, that will contain specific information about the
terms of the Class A common stock offered. Each prospectus
supplement may also add to, update or change the information
contained or incorporated by reference in this prospectus. You
should read both this prospectus and any applicable prospectus
supplement together with the information described under the
heading Where You Can Find More Information directly
below. In addition, a number of the documents and agreements
that we refer to or summarize in this prospectus have been filed
with the SEC as exhibits to the registration statement. Before
you invest in our Class A common stock, you should read the
relevant documents and agreements.
References to Moog refer to Moog Inc. Unless
otherwise indicated or the context otherwise requires,
references to we, us or our
refer collectively to Moog Inc. and its subsidiaries.
You should rely only on the information contained or
incorporated by reference in this prospectus and any prospectus
supplement. We have not authorized anyone else to provide you
with different information. Neither we, nor any other person on
our behalf, is making an offer to sell or soliciting an offer to
buy the Class A common stock described in this prospectus
or in any prospectus supplement in any state where the offer is
not permitted. You should not assume that the information in
this prospectus or any prospectus supplement, or any document
incorporated by reference in this prospectus and the applicable
prospectus supplement, is accurate as of any date other than
their respective dates. There may have been changes in our
affairs since such date.
We have not authorized any other person to provide you with any
information or to make any representation that is different
from, or in addition to, the information and representations
contained in this prospectus or in any of the documents that are
incorporated by reference in this prospectus. If anyone provides
you with different or inconsistent information, you should not
rely on it. You should assume that the information appearing in
this prospectus, as well as the information contained in any
document incorporated by reference, is accurate as of the date
of each such document only, unless the information specifically
indicates that another date applies.
WHERE YOU
CAN FIND MORE INFORMATION
We file annual, quarterly and current reports, proxy statements
and other information with the SEC. Our SEC filings are
available to the public over the Internet from the SECs
web site at
http://www.sec.gov.
You may also read and copy any document we file at the
SECs public reference room located at
100 F Street, NE, Washington, D.C. 20549. Please
call the SEC at
1-800-SEC-0330
for further information on the public reference room and their
copy charges.
The SEC allows us to incorporate by reference in
this prospectus the information in documents filed with it. This
means that we can disclose important information to you by
referring you to these documents. The information incorporated
by reference is considered to be a part of this prospectus, and
information in documents that we file later with the SEC will
automatically update and supersede information contained in
documents filed earlier with the SEC or contained in this
prospectus or any prospectus supplement.
We incorporate by reference in this prospectus the documents
listed below and any future filings that we may make with the
SEC under Sections 13(a), 13(c), 14 or 15(d) of the
Securities Exchange Act of 1934, or the Exchange Act, prior to
the termination of this offering. These additional documents
include periodic reports, such as annual reports on
Form 10-K,
quarterly reports on
Form 10-Q
and current reports on
Form 8-K
(other than information furnished under Items 2.02 and
7.01, which is deemed not to be incorporated by reference in
this prospectus). You should review these filings as they may
disclose a change in our business, prospects, financial
condition or other affairs after the date of this prospectus.
1
This prospectus incorporates by reference the documents listed
below that we have filed with the SEC but have not been included
or delivered with this document:
|
|
|
|
|
Our Annual Report on
Form 10-K
for the year ended September 27, 2008;
|
|
|
|
Our Quarterly Reports on
Form 10-Q
for the quarters ended December 27, 2008, March 28,
2009 and June 27, 2009; and
|
|
|
|
Our Current Reports on
Form 8-K
filed October 3, 2008, October 7, 2008,
October 30, 2008 (but only with respect to the disclosure
under Item 8.01 included in such report), November 14,
2008, December 31, 2008, January 23, 2009,
February 2, 2009, February 17, 2009, March 2,
2009, June 1, 2009, June 26, 2009, September 4,
2009, September 21, 2009 and September 28, 2009.
|
You may request a copy of these documents, at no cost to you, by
writing or telephoning us at:
Moog Inc.
Seneca St. at Jamison Rd.
Corporate Offices
East Aurora, NY 14052
Attention: Investor Relations
(716) 652-2000
Any statement made in this prospectus or any prospectus
supplement concerning the contents of any contract, agreement or
other document is only a summary of the actual document. You may
obtain a copy of any document summarized in this prospectus or
any prospectus supplement at no cost by writing to or
telephoning us at the address and telephone number given above.
Each statement regarding a contract, agreement or other document
is qualified in its entirety by reference to the actual document.
DISCLOSURE
REGARDING FORWARD-LOOKING STATEMENTS
This prospectus, including the documents we incorporate by
reference, and any applicable prospectus supplement contain
forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. These statements are included
throughout this prospectus, including in the sections entitled
Moog Inc. and Risk Factors. These
forward-looking statements are not historical facts, but only
predictions and generally can be identified by the use of terms
such as may, will, should,
believes, expects, expected,
intends, plans, projects,
estimates, predicts,
potential, outlook,
forecast, anticipates,
presume, assume, and terms and phrases
of similar import. Although we believe the assumptions upon
which these forward-looking statements are based are reasonable,
any of these assumptions could prove to be inaccurate, and the
forward-looking statements based on these assumptions could be
incorrect. While we have made these forward-looking statements
in good faith and they reflect our current judgment regarding
such matters, actual results could vary materially from the
forward-looking statements. Accordingly, these forward-looking
statements are qualified in their entirety by reference to the
factors described in Risk Factors appearing in this
prospectus and any accompanying prospectus as well as to other
information in this prospectus, any accompanying prospectus and
the documents incorporated by reference. The forward-looking
statements included in this prospectus are made only as of their
respective dates, and we undertake no obligation to publicly
update these forward-looking statements to reflect new
information, future events or otherwise. In light of these
risks, uncertainties and assumptions, the forward-looking events
might or might not occur. Actual results and trends in the
future may differ materially depending on a variety of important
factors. The factors identified below are not exhaustive. New
factors, risks and uncertainties may emerge from time to time
that may affect the forward-looking statements made herein.
Given these factors, risks and uncertainties, investors should
not place undue reliance on forward-looking statements as
predictive of future results.
2
Important factors, risks and uncertainties include:
|
|
|
|
|
fluctuations in general business cycles for commercial aircraft,
military aircraft, space and defense products, industrial
capital goods and medical devices;
|
|
|
|
our dependence on government contracts, that may not be fully
funded or may be terminated;
|
|
|
|
our dependence on certain major customers, such as The Boeing
Company and Lockheed Martin, for a significant percentage of our
sales;
|
|
|
|
delays by our customers in the timing of introducing new
products, which may affect our earnings and cash flow;
|
|
|
|
the possibility that the demand for our products may be reduced
if we are unable to adapt to technological change;
|
|
|
|
intense competition, which may require us to lower prices or
offer more favorable terms of sale;
|
|
|
|
our indebtedness, which could limit our operational and
financial flexibility;
|
|
|
|
the possibility that new product and research and development
efforts may not be successful, which could reduce our sales and
profits;
|
|
|
|
increased cash funding requirements for pension plans, which
could occur in future years based on assumptions used for our
defined benefit pension plans, including returns on plan assets
and discount rates;
|
|
|
|
a write-off of all or part of our goodwill or intangible assets,
which could adversely affect our operating results and net worth
and cause us to violate covenants in our bank agreements;
|
|
|
|
the potential for substantial fines and penalties or suspension
or debarment from future contracts in the event we do not comply
with regulations relating to defense industry contracting;
|
|
|
|
the potential for cost overruns on development jobs and
fixed-price contracts and the risk that actual results may
differ from estimates used in contract accounting;
|
|
|
|
the possibility that our subcontractors may fail to perform
their contractual obligations, which may adversely affect our
contract performance and our ability to obtain future business;
|
|
|
|
our ability to successfully identify and consummate
acquisitions, and integrate the acquired businesses and the
risks associated with acquisitions, including that the acquired
businesses do not perform in accordance with our expectations,
and that we assume unknown liabilities in connection with
acquired businesses for which we are not indemnified;
|
|
|
|
our dependence on our management team and key personnel;
|
|
|
|
the possibility of a catastrophic loss of one or more of our
manufacturing facilities;
|
|
|
|
the possibility that future terror attacks, war or other civil
disturbances could negatively impact our business;
|
|
|
|
that our operations in foreign countries could expose us to
political risks and adverse changes in local, legal, tax and
regulatory schemes;
|
|
|
|
the possibility that government regulation could limit our
ability to sell our products outside the United States;
|
|
|
|
product quality or patient safety issues with respect to our
medical devices business that could lead to product recalls,
withdrawal from certain markets, delays in the introduction of
new products, sanctions, litigation, declining sales or actions
of regulatory bodies and government authorities;
|
|
|
|
the impact of product liability claims related to our products
used in applications where failure can result in significant
property damage, injury or death and in damage to our reputation;
|
3
|
|
|
|
|
changes in medical reimbursement rates of insurers to medical
service providers, which could affect sales of our medical
products;
|
|
|
|
the possibility that litigation results may be unfavorable to us;
|
|
|
|
our ability to adequately enforce our intellectual property
rights and the possibility that third parties will assert
intellectual property rights that prevent or restrict our
ability to manufacture, sell, distribute or use our products or
technology;
|
|
|
|
foreign currency fluctuations in those countries in which we do
business and other risks associated with international
operations;
|
|
|
|
the cost of compliance with environmental laws;
|
|
|
|
the risk of losses resulting from maintaining significant
amounts of cash and cash equivalents at financial institutions
that are in excess of amounts insured by governments;
|
|
|
|
the inability to modify, to refinance or to utilize amounts
presently available to us under our credit facilities given
uncertainties in the credit markets;
|
|
|
|
our ability to meet the restrictive covenants under our credit
facilities since a breach of any of these covenants could result
in a default under our credit agreements; and
|
|
|
|
our customers inability to continue operations or to pay
us due to adverse economic conditions or their inability to
access available credit.
|
4
MOOG
INC.
Our Company
Overview
We are a worldwide designer, manufacturer and integrator of high
performance, precision motion and fluid controls and control
systems for a broad range of applications in aerospace and
defense, industrial and medical markets. Our aerospace and
defense products and systems include military and commercial
aircraft flight controls, satellite positioning controls,
controls for steering tactical and strategic missiles, thrust
vector controls for space launch vehicles, controls for gun
aiming, stabilization, and automatic ammunition loading for
armored combat vehicles, and homeland security products. Our
industrial products are used in a wide range of applications,
including injection molding machines, pilot training simulators,
wind energy, power generation, material and automotive testing,
metal forming, heavy industry and oil exploration. Our medical
products include infusion therapy pumps, enteral clinical
nutrition pumps, slip rings used on CT scanners, and motors used
in sleep apnea devices. For fiscal year 2008, our sales were
$1.903 billion, our net cash provided by operating activities
was $108 million and our net earnings were $119 million.
Our principal customers are Original Equipment Manufacturers, or
OEMs, and end users for whom we provide aftermarket support.
Aerospace and defense OEM customers collectively represented 44%
of our fiscal year 2008 sales. The majority of these sales were
to a small number of large companies. Due to the long-term
nature of many of the programs, many of our relationships with
aerospace and defense OEM customers are based on long-term
agreements. Our OEM sales of industrial and medical controls and
devices, which represented 38% of our fiscal year 2008 sales,
were to a wide range of global customers and were generally
based on lead times of 90 days or less. We also provide
aftermarket support, consisting of spare and replacement parts
and repair and overhaul services, for all of our product
applications. Our major aftermarket customers are the
U.S. Government and the commercial airlines. In fiscal year
2008, aftermarket sales accounted for 18% of total sales.
We have five operating segments: (1) Aircraft Controls,
(2) Space and Defense Controls, (3) Industrial
Systems, (4) Components, and (5) Medical Devices.
Our
Aircraft Controls Segment ($673 million, or 35%, of 2008
Sales)
Within Aircraft Controls, we design, manufacture and integrate
primary and secondary flight controls for military and
commercial aircraft, and provide aftermarket support. Our
systems are used in large commercial transports, supersonic
fighters, multi-role military aircraft, business jets and
rotorcraft. We also supply ground-based navigational aids.
We are well positioned on both development and production
programs. Typically, development programs require concentrated
periods of research and development by our engineering teams and
involve design, development, testing and integration. We are
currently working on several large development programs,
including the Lockheed Martin F-35 Joint Strike Fighter, Boeing
787 Dreamliner and Boeings extended range
747-8,
Airbus A350XWB and several business jet programs. The F-35 is in
the flight test phase and recently entered low rate initial
production. The 787 program began design and development in 2004
and is beginning to transition to production. The first flight
of the Boeing 787 Dreamliner is currently scheduled for the end
of calendar year 2009 with Boeings initial aircraft
delivery to occur by the end of calendar year 2010. The Airbus
A350XWB is in early stage development with entry into service
planned for 2013. Production programs are generally long-term
manufacturing efforts that extend for as long as the aircraft
builder receives new orders. Our large military production
programs include the
F/A-18 E/F
Super Hornet, the V-22 Osprey tiltrotor, the Black Hawk/Seahawk
helicopter and the F-15 Eagle. Our large commercial production
programs include the full line of Boeing 7-series aircraft,
Airbus A330/340 and a variety of business jets. Aftermarket
sales, which represented 32% of our fiscal year 2008 sales
for this segment, consist of the maintenance, repair, overhaul
and parts supply for both military and commercial aircraft. Our
aircraft products work in very demanding environments,
necessitating repair or replacement of parts from time to time.
Further, both our military and commercial customers throughout
the world carry spares inventory in order to minimize down time.
5
Our Space
and Defense Controls Segment ($253 million, or 13%, of 2008
Sales)
Our Space and Defense Controls segment provides controls for
satellites and space vehicles, armored combat vehicles, launch
vehicles, tactical and strategic missiles, homeland security and
other defense applications. For commercial and military
satellites, we design, manufacture and integrate steering and
propulsion controls and controls for positioning antennae and
deploying solar panels. The Atlas, Delta and Ariane launch
vehicle programs and the Space Shuttle use our steering and
propulsion controls. We are also developing products for the
Ares I launch vehicle and Orion crew vehicle on the
Constellation program, NASAs replacement for the Space
Shuttle. We supplied couplings, valves and actuators for the
International Space Station. We design and build steering and
propulsion controls for tactical and strategic missile programs,
including VT-1, Hellfire, TOW, Trident and Minuteman. We supply
valves and steering controls on the U.S. National Missile
Defense development initiative. We design and manufacture
systems for gun aiming, stabilization, automatic ammunition
loading and driver vision enhancement on armored combat vehicles
for a variety of international and U.S. customers,
including
Krauss-Maffei
Wegmann GmbH & Co. KG, Land Systems Hägglunds AB,
and General Dynamics. We also provide sensor and surveillance
systems for the homeland security market.
Our
Industrial Systems Segment ($532 million, or 28%, of 2008
Sales)
Industrial Systems serves a global customer base across a
variety of markets. Historically, our major markets have
included plastics making machinery, simulation, power
generation, test, metal forming and heavy industry. Sales into
those markets accounted for over 60% of our total sales in this
segment. The recent global recession has significantly affected
our sales in most of our industrial markets in 2009. For the
plastics making machinery market, we design, manufacture and
integrate systems for all axes of injection and blow molding
machines using leading edge technology, both hydraulic and
electric. We supply electromechanical motion simulation bases
for the flight simulation and training markets. In the power
generation market, we design, manufacture and integrate complete
control assemblies for fuel, steam and variable geometry control
applications that include wind turbines. For the test markets,
we supply controls for automotive, structural and fatigue
testing. Metal forming markets use our systems to provide
precise control of position, velocity, force, pressure,
acceleration and other critical parameters. Heavy industry uses
our high precision electrical and hydraulic servovalves for
steel and aluminum mill equipment. Other markets include oil
exploration, material handling, auto racing, carpet tufting,
paper and lumber mills. In addition, recent acquisitions have
allowed us to target wind energy as a new market. For wind
energy, we make electric rotor blade controls and blade
monitoring systems for wind turbines. We expect this new wind
energy market to be our strongest industrial market in 2010 as
measured by sales.
Our
Components Segment ($341 million, or 18%, of 2008
Sales)
The Components segment serves many of the same markets as our
other segments. The Components segments three largest
product categories are slip rings, fiber optic rotary joints and
motors.
Slip rings and fiber optic rotary joints accounted for
approximately 60% of our fiscal year 2008 sales for this segment
and use sliding contacts and optical technology to allow
unimpeded rotation while delivering power and data through a
rotating interface. They come in a range of sizes that allow
them to be used in many applications, including diagnostic
imaging CT scan medical equipment featuring high-speed data
communications, de-icing and data transfer for rotorcraft,
forward-looking infrared camera installations, radar pedestals,
surveillance cameras and remotely operated vehicles for offshore
oil exploration. Our motors are used in an equally broad range
of markets, many of which are the same as for slip rings.
Components designs and manufactures a series of miniature
brushless motors that provide extremely low noise and reliable
long life operation, with the largest market being sleep apnea
equipment. Industrial markets use our motors for material
handling and electric pumps. Military applications use our
motors for gimbals, missiles and radar pedestals.
Components other product lines include electromechanical
actuators for military, aerospace and commercial applications,
fiber optic modems that provide
electrical-to-optical
conversion of communication and data signals, avionic
instrumentation, optical switches and resolvers.
6
Our
Medical Devices Segment ($103 million, or 6%, of 2008
Sales)
This segment operates within four medical devices market areas:
infusion therapy, enteral clinical nutrition, sensors and
surgical handpieces. For infusion therapy, our primary products
are electronic ambulatory infusion pumps along with the
necessary administration sets as well as disposable infusion
pumps. Applications of these products include hydration,
nutrition, patient controlled analgesia, local anesthesia,
chemotherapy and antibiotics. We manufacture and distribute a
complete line of portable pumps, stationary pumps and disposable
sets that are used in the delivery of enteral nutrition for
patients in their own homes, hospitals and long-term care
facilities. We manufacture and distribute ultrasonic and optical
sensors used to detect air bubbles in infusion pump lines and
ensure accurate fluid delivery. Our surgical handpieces are used
to safely fragment and aspirate tissue in common medical
procedures such as cataract removal.
Our
Markets
We operate within the aerospace and defense, industrial and
medical markets. Our aerospace and defense markets are affected
by market conditions and program funding levels, while our
industrial markets are influenced by general capital investment
trends. Our medical markets are influenced by economic
conditions, hospital and outpatient clinic spending on
equipment, population demographics, medical advances and patient
demand. A common factor throughout our markets is the continuing
demand for technologically advanced products.
Aerospace
and Defense
The military aircraft market is dependent on military spending
for development and production programs. Production programs are
typically long-term in nature, offering predictability as to
capacity needs and future revenues. We maintain positions on
numerous high priority programs, including the F-35 Joint Strike
Fighter, the
F/A-18 E/F
Super Hornet and V-22 Osprey. The large installed base of our
products leads to attractive aftermarket sales and service
opportunities. Aftermarket revenues are expected to continue to
grow due to a number of scheduled military retrofit programs and
increased flight hours resulting from increased military
commitments.
The commercial OEM market has historically exhibited cyclical
swings and sensitivity to economic conditions. The aftermarket
is driven by usage of the existing aircraft fleet, the age of
the installed fleet and is currently being impacted by fleet
re-sizing programs for passenger and cargo aircraft. Changes in
aircraft utilization rates affect the need for maintenance and
spare parts and impact aftermarket sales. Boeing and Airbus have
historically adjusted production in line with air traffic volume.
The military and government space market is primarily dependent
on the authorized levels of funding for satellite
communications. Government spending on military satellites has
risen in recent years as the militarys need for improved
intelligence gathering has increased. The commercial space
market is comprised of large satellite customers, traditionally
telecommunications companies. Trends for this market, as well as
for commercial launch vehicles, follow telecommunications
companies need for increased capacity and the satellite
replacement lifecycle of 7-10 years. Our position on
NASAs Constellation program for crew transportation to the
Space Station and the exploration of the Moon, and possibly
Mars, holds the potential to be a long-run production program.
The tactical and strategic missile and defense controls markets
are dependent on many of the same market conditions as military
aircraft, including overall military spending and program
funding levels. Our homeland security product line is dependent
on government funding at federal and local levels, as well as
private sector demand.
Industrial
The industrial markets we serve are influenced by several
factors, including capital investment, product innovation,
economic growth, cost-reduction efforts and technology upgrades.
The industrial markets are experiencing challenges from current
global economic conditions. These challenges include reacting to
slowing demand for industrial automation equipment, steel and
automotive manufacturing and delayed orders
7
as customers manage inventory levels. Despite the general
slowdown in demand from the global recession, we continue to see
strong demand in the growing wind energy market.
Medical
The medical markets we serve are influenced by economic
conditions, hospital and outpatient clinic spending on
equipment, population demographics, medical advances, patient
demands and the need for precision control components and
systems. Advances in medical technology and medical treatments
have had the effect of extending the average life span, in turn
resulting in greater need for medical services. These same
technology and treatment advances also drive increased demand
from the general population as a means to improve quality of
life. Greater access to medical insurance, whether through
government funded health care plans or private insurance, also
increases the demand for medical services.
Our
Business Strengths
Since our founding in 1951, we have concentrated on providing
our customers with products designed and manufactured to the
highest quality standards. In achieving a leadership position in
the high performance, precision controls market, we have
capitalized on our strengths, which include:
Superior technical competence and customer intimacy breed
market leadership. Our innovative approach to
working closely with our customers to solve their controls needs
has been a very successful strategy for us. We attract and
retain some of the best and brightest engineers who have solved
some of the most difficult motion control problems. We designed
and supply the flight controls on the V-22 Osprey and F-35 Joint
Strike Fighter. By solving our customers complex design
and development challenges, we obtain substantial follow-on
production and aftermarket business. As a result, we believe we
are a leader in most of the markets we serve, including aircraft
flight controls, space and defense steering and fuel controls
and certain industrial controls.
Customer diversity and broad product
portfolio. We have focused on building our
business based on a balanced portfolio of OEM and aftermarket
customers. Aerospace and defense OEM customers collectively
represented 44% of our fiscal year 2008 sales, with the
majority of these sales to a small number of large companies.
Our OEM sales of industrial and medical controls and devices,
which represented 38% of our fiscal year 2008 sales, were
to a wide range of global customers. We also provide aftermarket
support, consisting of spare and replacement parts and repair
and overhaul services, for all of our product applications. Our
major aftermarket customers are the U.S. Government and the
commercial airlines. The breadth of our product range includes
electrohydraulic, electromechanical, electrohydrostatic and
electric controls as well as control software, allowing each of
our segments to reach numerous markets.
Well-established international presence serving customers
worldwide. We have a well-established
international presence throughout Europe, Asia and South
America. We entered mainland China in 1997, and our Chinese
operations have enjoyed rapid sales growth. Our reputation for
superior quality performance has helped to expand our marketing
reach in demanding global controls markets. Our network of
well-established subsidiaries in the Americas, Europe and Asia
allows us to effectively address our customers needs,
wherever they may be located. In fiscal year 2008, 20% of
our sales came from our European operations, 7% from our Asian
operations, and the balance were generated from the Americas,
predominantly the United States. Our principal manufacturing
operations are located in the United States, the Philippines,
Germany, England, Italy, Japan, China, Ireland, India and
Luxembourg.
Proven ability to successfully integrate
acquisitions. We have acquired numerous
companies over the last 15 years. Our success in
integrating these acquired businesses into our existing
operations and gaining the benefit of available synergies is
evidenced by our long-term sales growth and net earnings growth.
Our organic sales growth of 9% compounded annually for 1994 to
2008 complements our growth through acquisitions.
8
Our
Business Strategy
We intend to increase our revenue base and improve our
profitability and cash flows from operations by building on our
market leadership positions, by strengthening our niche market
positions in the principal markets we serve and by extending our
participation on the platforms we supply by providing more
systems solutions. We also expect to maintain a balanced,
diversified portfolio in terms of markets served, product
applications, customer base and geographic presence. Our
strategy to achieve our objectives includes:
Maintaining our technological excellence by building upon
our systems integration capabilities while solving our
customers most demanding technical
problems. Our historical commitment to
technological superiority is demonstrated by our past work on
significant programs such as the F-15 Eagle, B-2 stealth bomber,
Space Shuttle, Boeing 7 series, and V-22 Osprey. We believe our
successes in being selected to supply control systems on a
number of significant applications, including the F-35 Joint
Strike Fighter, Boeing 787, Airbus A350XWB, NASAs
Constellation program, electric motion simulators for flight
training, and flight control electronics on the high capacity
Boeing 747-8, demonstrate our commitment to remain on the
leading edge of technological advancements. These recent program
successes for the newer design and development initiatives serve
to further broaden our technological capabilities and strengthen
our market leadership position. By taking advantage of our
strong market share, particularly in the high-end precision
control markets, we continue to build our credentials as an
innovative, capable and reliable systems integrator and
subsystems supplier.
Taking advantage of our global
capabilities. Our global network of
international subsidiaries, in combination with our strong base
in the U.S., provides us with unique opportunities to reach
across the global markets we serve. For example, our aerospace
OEM activity is concentrated in the U.S. and Europe, while
our aerospace aftermarket business is global in nature. Our
industrial business is also global in nature. Our operating
philosophy is to identify centers of excellence for design,
manufacture and aftermarket service to enable our subsidiaries
to concentrate on what they do best. Certain of our subsidiaries
are staffed principally by sales and applications engineers who
then tap resources elsewhere in our network of companies. With
our objective of providing increasing value to our customers, we
are able to take advantage of the synergies that result from
sharing resources and capabilities across our operating units
throughout the world.
Growing our profitable aftermarket
business. We market spare and replacement
parts and repair services directly to our aerospace, industrial
and medical customers through our extensive network of
U.S. operations and international subsidiaries. Our
aftermarket business generally is more profitable than our OEM
business, and it provides a continuing revenue stream for many
years after the end of OEM production. We have a dedicated
customer service organization responsive to our aftermarket
customers needs.
Capitalizing on strategic acquisitions and
opportunities. We intend to enhance our
existing product offerings through continued investment in
independent research and development activities, teaming with
our customers in development initiatives, and selective,
strategic acquisitions. We have made several acquisitions that
have broadened our product offerings and markets we serve. A
recent example is the acquisition of LTi REEnergy GmbH. LTi
REEnergy specializes in the design and manufacture of servo
controllers as well as complete drive systems for electric rotor
blade controls for wind turbines, and provides us greater
opportunities in the wind energy market.
Entering and developing new markets. We
expect to expand our capabilities into new, growing markets by
focusing on markets that are compatible with our precision
controls competence. Recent examples are our entry into the
homeland security and medical devices markets. Our broad
expertise as a designer and supplier of precision controls
allows us to consider entering new markets, generally at the
high end of the performance spectrum.
Striving for continuing cost
improvements. We continue to pursue cost and
cycle time reductions using lean initiatives to improve
efficiency and maximize value to our stakeholders. Our
well-established low-cost manufacturing centers in the
Philippines and India provide us with a competitive advantage on
long-term production programs.
We were incorporated in New York in 1951. Our principal
executive offices are located at Seneca St. at Jamison Road,
East Aurora, New York 14052, and our telephone number is
(716) 652-2000.
Our internet address is www.moog.com. Our internet site is not
incorporated into this prospectus.
9
RISK
FACTORS
Investing in our Class A common stock involves a high
degree of risk. Before you invest in our Class A common
stock, you should understand and carefully consider the risks
described below and the risk factors relating to our industry
and business described in our Annual Report on
Form 10-K
for the year ended September 27, 2008, as well as all of
the other information contained in this prospectus, the
applicable prospectus supplement and the information
incorporated by reference, including our financial statements
and the related notes. Any of these risks could materially
adversely affect our business, financial condition, results of
operations and the trading price of our Class A common
stock, and you may lose all or part of your investment.
The
voting rights of the Class A common stock are
limited.
The voting rights of the holders of Class A common stock
are limited by our certificate of incorporation. Holders of
Class A common stock are entitled to elect at least 25% of
the board of directors, rounded up to the nearest whole number,
so long as the outstanding shares of Class A common stock
are at least 10% of the aggregate number of outstanding shares
of Class A common stock and Class B common stock
combined. Currently, the holders of Class A common stock
are entitled, as a class, to elect three directors. The holders
of the Class B common stock are entitled, as a class, to
elect the remaining eight directors. On all other matters except
as is required by law, the Class A and Class B common
stock vote together as a single class with each share of
Class A common stock entitled to a one-tenth vote per share
and each share of Class B common stock entitled to one vote
per share.
Our
officers and directors and shareholders affiliated with them
control the vote of a significant percentage of our voting stock
and as a result exert influence over us, and may have interests
that conflict with those of other shareholders, including
purchasers of Class A common stock.
As of September 24, 2009, 85.1% of the Class B common
stock and 4.9% of the Class A common stock was held in the
aggregate by the Moog Inc. Retirement Savings Plan Trust, the
Moog Inc. Retirement Plan Trust, relatives of the late Jane B.
Moog subject to The Moog Family Agreement as to Voting and our
officers and directors. These shareholders as a group possess
the voting power to elect a majority of the board of directors
and to effectively control our business policies and affairs,
and may have interests that conflict with those of other
shareholders, including purchasers of our Class A common
stock.
New York
law and our certificate of incorporation and by-laws contain
provisions that could delay and discourage takeover attempts
that shareholders may consider favorable.
Certain provisions of our certificate of incorporation and
by-laws and applicable provisions of New York corporate law may
make it more difficult for, or prevent, a third party from
acquiring control of us or changing our board of directors and
management. These provisions include:
|
|
|
|
|
the limited voting rights of the Class A common stock and
the fact that 4.9% of the Class A and 85.1% of the
Class B common stock, representing 48.1% of the voting
power of our outstanding common stock, is owned or controlled by
our affiliates;
|
|
|
|
our ability under our certificate of incorporation to issue
additional shares of Class B common stock and shares of
blank check preferred stock without action of the
shareholders;
|
|
|
|
provisions of our certificate of incorporation and by-laws which
create a staggered board of directors with each director elected
for a three-year term; and
|
|
|
|
provisions of New York corporate law which impose limitations on
persons proposing to acquire us in a transaction not approved by
our board of directors.
|
Any delay or prevention of a change of control transaction or
changes in our board of directors or management could deter
potential acquirors or prevent the completion of a transaction
in which our stockholders could receive a substantial premium
over the then-current market price for their shares.
10
Possible
volatility in the price of our common stock could negatively
affect us and our shareholders.
The trading price of our Class A common stock may be
volatile in response to a number of factors, many of which are
beyond our control, including actual or anticipated variations
in quarterly financial results, changes in financial estimates
by securities analysts and announcements by our competitors of
significant acquisitions, strategic partnerships, joint ventures
or capital commitments. In addition, our financial results may
be below the expectations of securities analysts and investors.
If this were to occur, the market price of our Class A
common stock could decrease, perhaps significantly.
Additionally, our Class A common stock has historically had
low trading volumes. The limited liquidity for holders of our
Class A common stock may add to the volatility of the
trading price of our common stock. For example, from
October 1, 2007 to September 24, 2009, the sales
prices of our Class A common stock have ranged from $17.90
per share to $56.47 per share. These effects could materially
adversely affect the trading market and prices for our
Class A common stock, as well as our ability to issue
additional securities or to secure additional financing in the
future.
In addition, the U.S. securities markets have experienced
significant price and volume fluctuations. These fluctuations
often have been unrelated to the operating performance of
companies in these markets. Broad market and industry factors
may negatively affect the price of our Class A common
stock, regardless of our operating performance.
Future
sales of shares of our common stock may depress its market
price.
Sales of substantial numbers of additional shares of common
stock, including shares of our Class A common stock, as
well as sales of shares that may be issued in connection with
future acquisitions or for other purposes, including to finance
our operations and business strategy, or the perception that
such sales could occur, may have a harmful effect on prevailing
market prices for our Class A common stock and our ability
to raise additional capital in the financial markets at a time
and price favorable to us.
You may
not receive dividends on our Class A common
stock.
Holders of our Class A common stock are only entitled to
receive such dividends as our board of directors may declare out
of funds legally available for such payments. Covenants
contained in our debt agreements limit the payment of dividends
on our Class A common stock. Furthermore, our articles of
incorporation permit our board of directors to declare and issue
preferred stock with dividend rights that rank prior in right of
payment to the Class A common stock without further
approval by holders of Class A common stock. We did not pay
cash dividends on our Class A common stock or Class B
common stock in 2007 or 2008 and have no plans to do so in the
foreseeable future.
Any
issuance of preferred stock could adversely affect the holders
of our Class A common stock.
Our board of directors is authorized to issue shares of
preferred stock or Class B common stock without any action
on the part of our shareholders. Our board of directors also has
the power, without shareholder approval, to set specified terms
of any series of preferred stock, including dividend rates,
votes per share, redemption prices and amounts payable in the
event of our dissolution, liquidation or winding up. Any
preferred stock that we issue may have a preference over our
Class A common stock with respect to the payment of
dividends and upon our liquidation, dissolution or winding up.
As a result, our board of directors could issue preferred stock
with dividend, liquidation and voting rights and with other
terms that could adversely affect the interests of the holders
of our Class A common stock.
11
USE OF
PROCEEDS
Unless otherwise indicated in the applicable prospectus
supplement, we expect to use the net proceeds from the sale of
the Class A common stock offered hereby for general
corporate purposes, which may include the repayment of our debt
obligations, capital expenditures, working capital and financing
acquisitions. Further details relating to the use of the net
proceeds of any of the Class A common stock will be set
forth in the applicable prospectus supplement.
12
PRICE
RANGE OF CLASS A COMMON STOCK
Our Class A common stock trades on the New York Stock
Exchange under the symbol MOG.A. The following table sets forth
for the quarters indicated the high and low sales prices as
reported by the New York Stock Exchange.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
Low
|
|
Fiscal 2007
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
40.50
|
|
|
$
|
33.91
|
|
Second Quarter
|
|
|
41.74
|
|
|
|
35.03
|
|
Third Quarter
|
|
|
45.16
|
|
|
|
40.22
|
|
Fourth Quarter
|
|
|
49.42
|
|
|
|
37.20
|
|
Fiscal 2008
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
49.19
|
|
|
$
|
41.18
|
|
Second Quarter
|
|
|
48.24
|
|
|
|
38.79
|
|
Third Quarter
|
|
|
46.37
|
|
|
|
37.46
|
|
Fourth Quarter
|
|
|
56.47
|
|
|
|
35.30
|
|
Fiscal 2009
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$
|
43.36
|
|
|
$
|
24.00
|
|
Second Quarter
|
|
|
39.58
|
|
|
|
17.90
|
|
Third Quarter
|
|
|
28.57
|
|
|
|
21.50
|
|
Fourth Quarter (through September 24, 2009)
|
|
|
33.17
|
|
|
|
22.93
|
|
The closing sale price of our Class A common stock on
September 24, 2009 as reported by the New York Stock
Exchange was $31.41 per share. As of September 24, 2009,
there were 1,073 record holders of our Class A common stock
and 478 record holders of our Class B common stock.
We intend to retain our earnings to finance the expansion of our
business and do not anticipate paying cash dividends on our
common stock in the foreseeable future. Any future determination
regarding cash dividends will be made by our board of directors
and will depend upon our earnings, financial condition, capital
requirements, any limitations in our financing agreements, and
other factors deemed relevant by the board. Payment of cash
dividends is permitted by our bank credit facility, with a
limitation on the aggregate amount of dividends that may be paid
to shareholders.
13
DESCRIPTION
OF CAPITAL STOCK
Our authorized capital stock consists of 100,000,000 shares
of Class A common stock, par value $1.00 per share,
20,000,000 shares of Class B common stock, par value
$1.00 per share and 10,000,000 shares of preferred stock,
par value $1.00 per share. As of September 24, 2009, we had
outstanding 38,492,674 shares of Class A common stock
and 4,139,606 shares of Class B common stock. As of
September 24, 2009, we had 1,699,886 shares of
Class A common stock issuable upon exercise of outstanding
stock options under our stock option plans at a weighted average
price of $26.27 per share, 13,192 shares of Class A
common stock reserved and available for future issuance under
our stock option plans, and 4,139,606 shares of
Class A common stock issuable upon conversion of our shares
of Class B common stock then outstanding. As of
September 24, 2009, no shares of preferred stock were
outstanding. The following description of our capital stock is a
summary only and is derived from our certificate of
incorporation, which is incorporated by reference into this
prospectus.
Common
Stock
The Class A common stock and Class B common stock
share equally in our earnings and are identical except with
respect to rights on voting, dividends and share distributions
and convertibility.
Voting Rights. The Class A common stock
and Class B common stock vote as a single class on all
matters except election of directors and except as required by
law. Holders of Class A common stock are entitled to elect
at least 25% of the board of directors, rounded up to the
nearest whole number, so long as the outstanding shares of
Class A common stock are at least 10% of the aggregate
number of outstanding shares of Class A common stock and
Class B common stock combined. The holders of Class B
common stock elect the remaining directors. Currently, the
holders of Class A common stock are entitled, as a class,
to elect three directors. The holders of the Class B common
stock are entitled, as a class, to elect our remaining eight
directors. Our by-laws provide that each class of directors is
further divided into three classes with staggered three-year
terms. On all other matters, the holders of Class A common
stock are entitled to one-tenth of a vote. Each share of
Class B common stock is entitled to one vote. If the
outstanding shares of Class A common stock become less than
10% of the aggregate number of outstanding shares of both
classes combined, the holders of Class A common stock would
not have the right to elect 25% of the board of directors.
Directors would then be elected by all shareholders voting as a
single class, with holders of Class A common stock having a
one-tenth vote per share and holders of Class B common
stock having one vote per share.
Dividends and Share Distributions. Dividends
may be paid on Class A common stock without paying a
dividend on Class B common stock. No dividend may be paid
on Class B common stock unless at least an equal dividend
is paid on Class A common stock. Payment of dividends is
limited by our bank credit facility.
Share distributions in shares of Class A common stock or
Class B common stock may be paid only as follows. Shares of
Class A common stock are paid to holders of shares of
Class A common stock or, if there is no Class A common
stock outstanding, to holders of Class B common stock.
Shares of Class A common stock are paid to holders of
Class A common stock and shares of Class B common
stock are paid to holders of Class B common stock. The same
number of shares must be paid in respect of each outstanding
share of Class A common stock and Class B common stock.
We may not combine or subdivide shares of either class of common
stock without at the same time proportionally subdividing or
combing shares of the other class.
Conversion. Each share of Class B common
stock is convertible at the option of the holder at any time
into Class A common stock on a
one-for-one
basis.
Preferred
Stock
Our board of directors is authorized, without shareholder
action, to issue shares of preferred stock in one or more
series. The board has the discretion to determine the rights,
preferences and limitations of each series, including voting
rights, dividend rights, conversion rights, redemption
privileges and liquidation preferences. Satisfaction of any
dividend preference of outstanding shares of preferred stock
would reduce the amount of funds
14
available for the payment of dividends on shares of common
stock. In some circumstances, the issuance of shares of
preferred stock may render more difficult or tend to discourage
a merger, tender offer or proxy contest, the assumption of
control by a holder of a large block of our securities or the
removal of incumbent management. We have no current intention to
issue any shares of preferred stock.
PLAN OF
DISTRIBUTION
We may sell the Class A common stock being offered hereby
in one or more of the following ways from time to time:
|
|
|
|
|
to underwriters or dealers for resale to the public or to
institutional investors;
|
|
|
|
directly to institutional investors; or
|
|
|
|
through agents to the public or to institutional investors.
|
The prospectus supplement will state the terms of the offering
of the Class A common stock, including:
|
|
|
|
|
the name or names of any underwriters or agents;
|
|
|
|
the purchase price of the Class A common stock and the
proceeds to be received by us from the sale;
|
|
|
|
any underwriting discounts or agency fees and other items
constituting underwriters or agents compensation;
|
|
|
|
any initial public offering price;
|
|
|
|
any discounts or concessions allowed or reallowed or paid to
dealers; and
|
|
|
|
the securities exchange on which the Class A common stock
may be listed.
|
If we use underwriters in the sale, the Class A common
stock will be acquired by the underwriters for their own account
and may be resold from time to time in one or more transactions,
including:
|
|
|
|
|
negotiated transactions;
|
|
|
|
at a fixed public offering price or prices, which may be changed;
|
|
|
|
at market prices prevailing at the time of sale;
|
|
|
|
at prices related to prevailing market prices; or
|
|
|
|
at negotiated prices.
|
The Class A common stock may also be offered and sold, if
so indicated in the prospectus supplement, in connection with a
remarketing upon their purchase, in accordance with a redemption
or repayment pursuant to their terms, or otherwise, by one or
more remarketing firms, acting as principals for their own
accounts or as agents for us. The prospectus supplement will
identify any remarketing firm and will describe the terms of its
agreement, if any, with us and its compensation.
Unless otherwise stated in a prospectus supplement, the
obligations of the underwriters to purchase any Class A
common stock will be conditioned on customary closing conditions
and the underwriters will be obligated to purchase all of such
Class A common stock, if any are purchased.
Underwriters, dealers, agents and remarketing firms may be
entitled under agreements entered into with us to
indemnification by us against certain civil liabilities,
including liabilities under the Securities Act, or to
contribution with respect to payments which the underwriters,
dealers, agents and remarketing firms may be required to make.
Underwriters, dealers, agents and remarketing agents may be
customers of, engage in transactions with, or perform services
in the ordinary course of business for us
and/or our
affiliates.
The Class A common stock sold will be listed on the New
York Stock Exchange, upon official notice of issuance. Any
underwriter to whom the Class A common stock is sold by us
for public offering and sale may make a
15
market in the Class A common stock, but such underwriter
will not be obligated to do so and may discontinue any market
making at any time without notice. Any underwriter or agent
involved in the offer or sale of the Class A common stock
will be named in the applicable prospectus supplement.
In compliance with guidelines of the Financial Industry
Regulatory Authority, or FINRA, the maximum consideration or
discount to be received by any FINRA member or independent
broker dealer may not exceed 8% of the aggregate amount of the
securities offered pursuant to this prospectus and any
applicable prospectus supplement.
LEGAL
MATTERS
Unless otherwise indicated in this prospectus, Hodgson Russ LLP,
Buffalo, New York will provide us with an opinion regarding the
validity of the Class A common stock offered hereby. John
Drenning, our Corporate Secretary, is a partner in Hodgson Russ
LLP. He and other attorneys in that firm beneficially own an
aggregate of approximately 10,500 shares of Class A
common stock.
EXPERTS
The consolidated financial statements and related financial
statement schedule of Moog Inc. appearing in Moog Inc.s
Annual Report
(Form 10-K)
for the year ended September 27, 2008 and the effectiveness
of Moog Inc.s internal control over financial reporting as
of September 27, 2008, have been audited by
Ernst & Young LLP, independent registered public
accounting firm, as set forth in their reports thereon included
therein and incorporated herein by reference. Such consolidated
financial statements have been incorporated herein by reference
in reliance upon such reports given on the authority of such
firm as experts in accounting and auditing.
16
2,500,000 Shares
Class A Common
Stock
PROSPECTUS SUPPLEMENT
Cowen and Company
,
2009